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ABSTRACT 
    The best way to prevent infectious disease is to directly establish mucosal immunity 
and also induce circulatory immunity to avoid pathogen invasion and spread. In our first 
study, we tested the hypothesis that a single mucosal or subcutaneous administration of 
antigen immunotargeted to chicken CD40 can effectively target antigen-presenting cells 
(APCs) of the mucosal associated lymphoid tissue (MALT) and induce specific mucosal 
sIgA and circulatory IgG. Levels of peptide-specific tracheal mucosa sIgA and 
circulatory IgG were measured on day 7 and 14 post-injection (p.i.) by ELISA. The 
results indicated that a single subcutaneous (s.c.) injection of anti-chCD40 guided 2C5-
peptide complex not only induced a rapid and strong systemic peptide-specific IgG 
immune response, but also established a significant mucosal sIgA immune response.  
   Currently, only a few APC-specific markers and monoclonal antibodies (Mabs) are 
available in chicken. In mice, peritoneal exudate macrophages (PEMs) have been 
demonstrated to express the M1 phenotype and display CD62L on their cell surface, 
which allows them to migrate to lymph nodes as functional APCs. This makes chicken 
inflammatory-type PEMs a potential target for generating Mabs. However, the 
functional phenotype of chicken PEMs has yet to be elucidated. In the second and third 
study, we defined the functional phenotypes of two chicken macrophage models 
(Sephadex- and egg yolk-PEMs, S- and Y-PEMs) and generated Mabs against S-PEMs. 
The results suggest that arginase activity, the gene expression of the SOCS1/STAT3 axis, 
and the SOCS1/SOCS3 ∆Ct ratio, cannot be used as markers for phenotyping in 
chickens as in mice. Our results demonstrate that S-PEMs skew the phenotype to the M1 
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side and Y-PEMs shift the phenotype towards M2.  In the final study, three new Mabs 
against S-PEMs were generated. Two candidate antigens, CD110 and Fat 1, were 
recognized by 3F6 Mab using a 7-mer peptide phage display library. In mice, the 
expression of CXCR4 mRNA (a homing receptor) was shown to be up-regulated in the 
presence of thrombopoietin-CD110 ligation, which suggests that S-PEMs may have the 
potential to migrate to peripheral lymphoid tissues to function as APCs in the chicken.  
    The poultry industry needs a new generation of vaccines to induce both mucosal and 
systemic immunity in a single immunization. The antibody-guided CD40-targeting 
concept described in this dissertation provides a new platform that can fit this need.  
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CHAPTER I 
INTRODUCTION  
    Antigen-presenting cells [APCs; including dendritic cells (DCs), B-cells and 
macrophages] are the bridge between innate and adaptive immunity. Recently, a study 
from our lab described that an anti-CD40 Mab complexed with a synthetic peptide 
targeted to APCs can induce a rapid (as early as 4 days post-immunization) and robust 
systemic IgG response after a single subcutaneous (s.c.) injection (Chen et al., 2012). 
The results demonstrate the capacity of a CD40-targeted vaccine to induce a rapid and 
strong immune response, and most importantly, the capability to induce an 
immunoglobulin class switch from IgM to IgG. Theoretically, via the interconnected 
common mucosal immune system, mucosal immunity can be established at the effector 
sites of the mucosal associated lymphoid tissue (MALT) by immunization at the MALT 
inductive sites through different routes of administration (Barr et al., 2005). The first 
goal of this project was to test the hypothesis that a single mucosal administration of 
antigens immunotargeted to chicken CD40 can effectively target APCs of the MALT and 
induce a specific sIgA response.  
    Given the success of targeting APCs via CD40 as a new vaccination strategy, 
extending our repertoire of new monoclonal antibodies (Mabs) against APCs is a topic 
that is of considerable interest to our laboratory (lab). Currently, only a few APC specific 
markers and Mabs are available in chicken, including CD40 and our anti-chCD40 
monoclonal antibody (Mab). Ideally, our next target for Mab production would use 
recombinant DNA technology expressed chicken CD11c or CD205 as immunogen, 
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because in mammals, both receptors have been reported as useful targets for in vivo 
immunogen targeting (Cheong et al., 2010). However, the chicken CD11c ortholog has 
not been identified in the chicken genome, and repeated efforts to make antibodies 
against CD205 have failed due to a lack of a suitable immunogen. Therefore, we decided 
to use primary chicken macrophages as our immunogen and attempt to identify the 
cognate antigens of any resulting Mabs post facto. In chicken, peritoneal exudate 
macrophage (PEM) is the major (perhaps the only) source of obtaining relatively 
abundant of primary macrophage.  
    In mice, PEMs in the murine macrophage model have recently been shown to 
preferentially express M1 functional phenotypic characteristics by use of functional 
assays and gene expression profiling (Corna et al., 2010; Sica and Mantovani, 2012; 
Tenbusch et al., 2013). More importantly, mouse PEMs expressed CD62L (L-Selectin), 
supporting the idea that upon appropriate stimulation, PEMs may migrate to lymph 
nodes and serve as APCs (Ghosn et al., 2010; Idoyaga et al., 2011). These features make 
PEMs an ideal alternative antigen source (next to recombinant DNA technology), for the 
development of Mabs to explore the receptors expressed on APCs.  
    Chicken PEMs are the major source of macrophages for the study of chicken 
macrophage biology (Sabet et al., 1977). Currently, two chicken PEM models are 
available, i.e. those induced by i.p. injection of either Sephadex G-50 or by injection of 
yolk particles, and apparently these stimuli elicit cells with different features (Cornax et 
al., 2013; Golemboski et al., 1990).  Sephadex-elicited PEMs (S-PEMs) display 
characteristics of an increasingly activated state over time and can effectively bind, 
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internalize, and degrade bacteria by lysosomal acid hydrolysis (Golemboski et al., 1990).  
Upon i.p. injection with egg yolk, chicken blood monocyte-derived macrophages express 
anti-inflammatory and scavenger properties (Cornax et al., 2013). However, it is still 
unclear if egg yolk skews the phenotype of macrophages towards M2, and the details of 
the functional phenotype and mechanism of macrophage polarization under the influence 
of egg yolk remains to be elucidated. Based on preliminary evidence, we hypothesize 
that S-PEMs display a phenotype skewed towards M1, the inflammatory phenotype, and 
that egg yolk-PEMs (Y-PEMs) display an M2 macrophage, anti-inflammatory 
(scavenger) phenotype. Since our ultimate goal is to verify the cell markers recognized 
by new Mabs produced against S-PEMs, it become important to gain information about 
the functional phenotypes of S-PEMs. At the same time, we also investigated the 
functional phenotypes of other primary chicken macrophage model, Y-PEMs.  
Therefore as the second goal of this project, we propose to evaluate the phenotypes of 
S- and Y-PEMs by use of functional assays (arginase and NOS activity assays) and 
through gene expression profiling. The plasticity of macrophage polarization was 
evaluated by exposing both sources of macrophages to LPS (a strong M1 inducing 
stimulant). The results were used as reference for the third part of this project: 
development and characterization of new Mabs against chicken peritoneal exudate 
macrophages. 
    In the third and final goal of this study, we tested the hypothesis that S-PEMs are a 
good source of antigen for Mab development against APCs, more specifically M1 
macrophages. Cell surface markers are the mainstay for macrophage phenotyping 
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research. However, identifying chicken macrophage phenotypes remains a challenge 
because only a few Mabs against chicken macrophage cell surface markers are 
commercially available, and many well-identified murine cell markers, like F4/80 and 
CD11b, are not yet available in for use in the chicken.     
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CHAPTER II  
REVIEW OF LITERATURE 
 
Mucosal associated lymphoid tissue (MALT)  
    Mucosal surfaces are the major portal of pathogens entering the host and represent the 
largest surface area in contact with the external environment.  Collectively, they can also 
be considered the largest organ system in vertebrates. Animal pathogens enter the host 
by breaching the mucosal barrier, which consists of specialized tissues characterized by 
an externally located epithelium and underlying connective tissue. Due to a continuous 
challenge by new materials and microorganisms, including pathogenic microorganisms, 
the immunological activity at the mucosal interface is intense. A wide variety of 
protective mechanisms are involved in mucosal immunity, ranging from barrier 
functions to highly specialized immune cells and organized lymphoid structures, in order 
to prevent the entry of pathogens through the mucosal tissues. In particular, the mucosal 
immune systems of the respiratory, digestive, and reproductive tract have highly 
developed lymphoid tissues called mucosal associated lymphoid tissue (MALT). MALT 
is stretched out from the gut [gut-associated lymphoid tissue (GALT)] and respiratory 
[nasal (NALT) and bronchus- (BALT) associated lymphoid tissues] tracts, to eyelids 
[conjunctiva-associated lymphoid tissue (CALT)] in chickens.  
    The MALT represents a highly compartmentalized immunological system and 
functions essentially independently from the systemic immune apparatus (Holmgren and 
Czerkinsky, 2005). MALT is comprised of 1) inductive sites such as the Peyer’s patches, 
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the appendix, and solitary follicles in the intestine (such as the cecal tonsils) where the 
immune response is initiated, and 2) diffuse effector sites such as the lamina propria of 
the gut where mucosal immune effector mechanisms (such as secretory IgA) are at work. 
The mucosal sites are interconnected by a common mucosal immune system (CMIS) 
enabling the induction and regulation of host-protective immunity against an invading 
pathogenic microorganism (Barr et al., 2005; Holmgren and Czerkinsky, 2005). 
Secretory IgA is one of the critical components in mucosal effector function. It is largely 
protease resistant and can therefore bind and neutralize pathogens or toxins in the 
mucosal sites.   
 
The Common Mucosal Immune System (CMIS) 
    The CMIS is an integrated pathway that allows communication between the inductive 
sites at the MALT and the diffuse mucosal effector sites, enabling the induction and 
regulation of host-protective immunity against pathogenic microorganisms.  The CMIS 
has been well defined in mammals, and an overview of the system is presented in Fig. 1. 
The mechanism of CMIS starts with antigen transportation. Luminal antigens are 
transcytosed to the MALT inductive sites by adsorptive epithelial cells or microfold (M-) 
cells that are present in the epithelium overlaying the lymphoid follicles at the inductive 
sites. Upon transcytosis, those antigens are directly captured by antigen-presenting cells 
[APCs; including dendritic cells (DCs), B-cells, and macrophages]. M-cells have special 
properties for the transportation of antigens across the epithelial barrier (epithelial cells 
held together by tight junctions) (Neutra and Kozlowski, 2006). APCs (a DC in Fig. 1) 
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Figure 1. The common mucosal immune system (Barr et al., 2005). The common mucosal immune system is an 
integrated pathway that connects the mucosal inductive sites (e.g. Peyer’s patches) and effector sites in MALT (e.g. 
intestinal lamina propria). Luminal antigens are transcytosed to the MALT inductive sites by adsorptive epithelial cells or 
microfold (M) cells. Upon transcytosis, those antigens are directly captured by antigen-presenting cells [APCs; including 
dendritic cells (DCs), B-cells, and macrophages]. Dendritic cells process and present antigen to CD4
+
 T-cells. Activated 
CD4
+
 T-cells temporally express CD154 on their cell surface allowing them to engage with CD40 expressing B-cells. 
CD40-CD154 ligation stimulates B-cell differentiation and class-switching from IgM- to IgA-committed B-cells. IgA
+
 B-
cells rapidly migrate from inductive sites to peripheral lymph nodes through the efferent lymphatics. Finally, under the 
influence of chemokines produced in the local microenvironment, antigen-specific CD4
+
 T-cells and IgA
+
 B-cells start to 
express homing receptors, such as CCR10, and migrate to effector sites through the thoracic duct and the blood 
circulation. IgA
+
 B-cells and plasmablasts then differentiate into IgA-producing plasma cells in the presence of 
interleukin-5 (IL-5) and IL-6, which are produced by T helper 2 (TH2) cells, and they subsequently produce dimeric forms 
of IgA. These dimeric forms of IgA then become secretory IgA (sIgA) by binding to polymeric Ig receptors, becoming 
the secretory component in the process of secretory IgA formation. Secretory IgA are displayed on the monolayer of 
epithelial cells lining the mucosa. 
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process and present antigens to conventional CD4
+
 and CD8
+
 αβ T-cells in the follicles 
located at the inductive sites. Certain antigens may also be processed and presented 
directly to neighboring intra-epithelial T-cells and natural killer (NK) cells with limited 
repertoire diversity, which then results in the suppression of a specific immune response 
(Holmgren and Czerkinsky, 2005). CD4
+
 T cells are activated by pathogens harboring 
motifs that are sensed as danger signals (danger-associated molecular patterns, or 
DAMPS) delivered by DCs. Activated CD4
+
 T cells then temporally express CD154 on 
their cell surface and engage with CD40 expressed on B-cells. The engagement of 
CD154 and CD40 induces class-switching, affinity maturation, and proliferation of B-
cells, thereby enhancing the terminal differentiation process from IgM-producing B-cells 
to IgA- or IgG-committed B-cells in the germinal center (GC) of the lymphoid follicle 
(Iwasaki, 2007). B-cells rapidly migrate from inductive sites to the regional peripheral 
lymph nodes through the efferent lymphatics.  
    B-cell homing to mucosal and peripheral tissues is mediated by specific combinations 
of chemokine receptors and adhesion molecules. After encountering antigen in the 
mucosal inductive sites, the B-cell is activated. This results in the up-regulation of 
CCR10 and expression of α4β1 integrin, which mediates attraction to CCL28 and 
VCAM-1 respectively, on various effector sites of BALT, NALT, and GALT (Fig. 2) 
(Macpherson et al., 2008). Within the GALT, the activation of B- cells additionally 
induces strong expression of CCR9 and α4β7, directing homing back to the effector sites 
in GALT, which express CCL25 and MAdCAM-1 (Fig. 2). Shared paring of homing 
receptors and addressins explain how activated IgA-producing lymphocytes from one 
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                                                                                                 (Macpherson et al., 2008) 
 
 
 
 
 
 
 
 
Figure 2. Mechanism of B-cell homing (Macpherson et al., 2008). B-cell homing to 
mucosal and peripheral tissues is mediated by specific chemokine receptors (homing 
receptors) and adhesion molecules (addressins). In general, IgA
+
 B-cells induce CCR10 
and α4β1 integrin expression, mediating attraction to CCL28 and VCAM-1 that are 
expressed in specific  target tissues (effector sites), respectively. 
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mucosal inductive site can populate other effector sites with IgA-producing cells. It is 
this phenomenon that gave rise to the concept and terminology of a “common mucosal 
immune system.” 
    Finally, under the influence of chemokines produced in the local microenvironment as 
mentioned above, antigen-specific CD4
+
 T-cells and IgA
+
 B-cells start to express 
homing receptors and migrate to effector sites (such as the lamina propria in the intestine) 
through the thoracic duct and blood circulation. IgA
+
 B-cells and plasmablasts then 
differentiate into IgA-producing plasma cells in the presence of interleukin-5 (IL-5) and 
IL-6, which are produced by T helper 2 (TH2) cells, and they subsequently produce 
dimeric forms of IgA. These dimeric forms of IgA then become secretory IgA (sIgA) by 
binding to polymeric Ig receptors, becoming the secretory component in the process of 
secretory IgA formation. Secretory IgA are displayed on the monolayer of epithelial 
cells lining the mucosa (Barr et al., 2005; Holmgren and Czerkinsky, 2005). 
    Compared to mammals, chickens lack well-organized, encapsulated lymphoid nodes; 
however, they developed diffuse lymphoid aggregations (nodules) instead (Muir et al., 
2000). Despite the anatomical and organizational differences, a similar gateway has been 
reported (Muir et al., 2000; Smialek et al., 2011). The structure of mucosal inductive 
sites in chicken (e.g. Peyer’s patches) is similar to those in mammals (Befus et al., 1980). 
IgA
+
 B-cell trafficking through the circulation between mucosal inductive and effector 
sites in GALT or between the Harderian gland and ceca tonsils has also been observed 
(Akaki et al., 1997; Muir et al., 2000). The cellular traffic between GALT and systemic 
sites, including bone marrow and spleen, has also been reported
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CD40 
    CD40, an integral membrane glycoprotein belonging to the TNF-receptor super 
family, is a co-stimulatory molecule and found on all the professional APCs, including 
B-cells, macrophages, and dendritic cells (van Kooten and Banchereau, 2000). CD40 
and its immunomodulating ligand, CD154 (CD40L), play essential roles in the cell 
immune response. CD154 is transiently expressed on activated CD4
+
 T-cells and the 
ligation of CD154 to the CD40 receptor on APCs provides the critical signal required for 
downstream events, such as APC activation. The activation of APCs results in up-
regulation of MHC-II and CD40 expression, increased expression of CD80/86, enhanced 
production of cytokines (mostly IL-12), and increased cross-priming of exogenous 
antigens to cytotoxic T-cells (Grewal and Flavell, 1996; Hernandez et al., 2007; Noelle, 
1996). These outcomes are critical for optimal priming and expansion of antigen-specific 
effector and memory T-cells, B-cell responses, and immunoglobulin class switching 
(Gordon and Pound, 2000). It has been clearly demonstrated that a primary defect in 
CD40-CD154 engagement is associated with human hyper-IgM syndrome, also known 
as immunoglobulin class switch recognition (CSR) deficiencies, and immune 
deficiencies found in CD4 knockout mice (Callard et al., 1993; Monson et al., 2001). 
CD40-CD154 deficient mice also exhibit defects in both humoral and the cellular 
immune responses, such as an impaired ability of APCs to deliver enhanced antigen 
presentation to cytotoxic T-cell (Carlring et al., 2011). 
    In mammals and chicken, anti-CD40 Mabs and recombinant CD154 have been 
successfully used to mimic T-cell help (i.e. to exert “agonistic” biological activities), and 
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to thus manipulate the activity of APCs, both in vitro and in vivo (Bennett et al., 1998; 
Chen et al., 2010a; Kothlow et al., 2008). In mice, agonistic monoclonal antibodies 
(Mabs) against (mouse) CD40 have also been shown to directly mimic T-cell help in 
vivo, in response to both T-cell dependent and independent antigens (Barr and Heath, 
1999; French et al., 1999). Direct mimicking of T-cell help to B-cells by agonistic anti-
CD40 Mabs may have therapeutic value in T-cell deficiency syndromes such as AIDS 
and hyper-IgM syndrome (Barr et al., 2003). Recently, agonistic CD40 Mabs were 
reported to offer new therapeutic opportunities against cancer by activating APCs and 
promoting anti-tumor T-cell responses, and by fostering cytotoxic myeloid cells with the 
potential to control cancer in the absence of T-cell immunity (Khong et al., 2012; 
Vonderheide and Glennie, 2013). The role of CD40 in lymphocyte migration has been 
discussed in the murine model by (von Bergwelt-Baildon et al., 2006). CD40-activated 
B-cells can be cellular adjuvants: they can prime naïve T-cells, expand memory T-cells, 
and stimulate their migration toward secondary lymphoid tissues.  B-cells displaying 
activated CD40 signaling have been reported to express homing receptors such as 
CD62L, CCR7/CXCR4, and CD11a/CD18, which are crucial for homing to secondary 
lymphoid tissues. Moreover, soluble polyclonal anti-CD40 has been described to induce 
CCR10 expression on memory B-cells in vitro in mammals (Bernasconi et al., 2002). 
This is important because CCR10 is a homing receptor on IgA-secreting B-cells. 
    Agonistic anti-CD40 Mabs can be immuno-potentiators when chemically conjugated 
with antigen, and the adjuvant effect can be attained against any physically attached 
antigen, inducing antigen-specific immune responses in both mammals and chickens 
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(Barr et al., 2006; Barr et al., 2003; Chen et al., 2012; Hatzifoti and Heath, 2007). 
Recently, a study from our lab described that an APC-targeting anti-CD40 Mab 
complexed with a synthetic peptide can induce a rapid and robust systemic IgG response 
after a single subcutaneous (s.c.) injection (Chen et al., 2012). The result demonstrates 
the capacity of a CD40-targeted immunogen to induce a rapid and strong immune 
response, and most importantly, the capability to induce immunoglobulin class switching 
from IgM to IgG. 
 
Antibody-guided vaccination targeting CD40 
    While there is great potential for novel vaccines based on recombinant proteins and 
synthetic peptides, such antigens often lack the immunogenicity of whole, killed 
pathogens used in traditional vaccines. Therefore, development of potent immunological 
adjuvants with low reactogenicity and high potential to enhance humoral immune 
responses are needed (Barr et al., 2003). Arguably one of the most successful strategies 
to attain this goal consists of attaching the antigen to an antibody against a co-
stimulatory cell surface receptor expressed by APCs, such as CD40 (Barr et al., 2005). A 
novel strategy of vaccine development using agonistic anti-CD40 antibody Mabs, was 
reported to act directly on APCs, resulting in this desired combination of low 
reactogenicity and high immunogenicity. This strategy was reportedly able to enhance 
humoral immune responses 1,000-fold compared with the use of an aluminum based 
adjuvant, and avoided the inflammatory side effects induced by most adjuvants (Barr et 
al., 2005; Hamzah et al., 2008). Agonistic anti-CD40 antibodies not only target antigen 
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delivery and activate B-cells, but also induce antibody class-switching. Murine and 
human naïve B-cells can be activated with anti-CD40 Mabs or CD40L (CD154) to 
undergo class switch recombination in vitro (Peterson et al., 2006). This is crucial, 
because IgA is readily transported across the intestinal mucosa and is endowed with 
effector properties that are critical for the local humoral immune response (Ravn et al., 
2007).  
 
Macrophages 
    Macrophages belong to the mononuclear phagocyte system and play a crucial role in 
both the innate and adaptive immune system. Moreover, macrophages fulfill homeostatic 
functions beyond their role in defense, such as tissue remodeling during ontogenesis and 
orchestration of metabolic functions (Sica and Mantovani, 2012). Macrophages originate 
from myeloid (MP) committed precursors derived from bone marrow hematopoietic 
stem cells. Under the influence of granulocyte macrophage colony stimulating factor 
(GM-CSF), MPs differentiate into monocyte precursors first, which will then further 
differentiate into monocytes. Finally, monocytes leave the bone marrow and enter the 
blood circulation. After about one day (in humans) or three days (in chickens and mice) 
of patrolling in the blood circulation, monocytes migrate and seed various tissues and 
organs; upon migration, they subsequently differentiate into macrophages (Geissmann et 
al., 2010; Qureshi et al., 2003; Tacke and Randolph, 2006). 
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Macrophage activation and polarization  
    Phenotyping cells in the mononuclear phagocyte system, which includes macrophages 
and dendritic cells (based on the expression of cell surface markers such as CD11b, 
CD68, and F4/80), has been the mainstay of macrophage characterization in the murine 
model (Murray and Wynn, 2011a). In contrast to the progress in the murine model, 
corresponding avian subsets are yet to be elucidated due to the fact that very few 
monoclonal antibodies (Mabs) against markers expressed by avian mononuclear 
phagocytes are available. M1 macrophage refers to macrophages that have been exposed 
to Toll-like receptor (TLR) ligands/interferon-γ (IFN-γ). They not only possess potent 
microbicidal properties through the production of NO and reactive oxygen intermediates, 
but also promote strong interleukin-1 (IL-1), IFN-γ, and IL-12-mediated Th1 responses 
through secretion of pro-inflammatory cytokines. In contrast, M2 macrophages produce 
anti-inflammatory cytokines, such as IL-4/IL13 and IL-10, and are mainly associated 
with Th2 effector functions, such as anti-parasitic activity and tissue repair through 
production of polyamines and proline (Sica and Mantovani, 2012).   
    In the mouse, M2 macrophages can be further divided into three subpopulations: M2a, 
(after exposure to IL-4/13), M2b (after exposure to immune complexes in combination 
with IL-1β or LPS), and M2c (induced by IL-10, tumor growth factor- β (TGF-β) or 
glucocorticoids) (Martinez et al., 2009). M2 macrophages also synthesize arginase, an 
enzyme that inhibits NO production and allows the cells to produce ornithine, a 
precursor of polyamines and proline, instead (Chang et al., 1998). Interestingly, although 
M1 and M2 macrophages display distinct phenotypes, the essential metabolic substrate 
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that drives M1 and M2 macrophages through different pathways is the same amino acid 
L-arginine (Stempin et al., 2010).  Chicken HD11 cells produce abundant NO and 
secrete pro-inflammatory cytokines upon exposure to Toll-like receptor (TLR) ligands, 
or pathogens such as Campylobacter jejuni (Smith et al., 2005). However, the 
polarization of avian primary macrophages has yet to be addressed in detail (He et al., 
2011).   
 
Gene markers in macrophage phenotyping   
    Recently, various genes have been reported as being preferentially expressed in either 
M1 or M2 macrophages (Table 1). These observations would be particularly useful if 
they could be extended to chicken macrophages, as the equivalent of some reliable 
mammalian macrophage markers does not exist in chicken. 
 
SOCS3 vs. SOCS1 
    Suppressor of cytokine signaling (SOCS) molecules are a family of intracellular 
proteins, several of which have emerged as feedback inhibitors of the Janus kinase 
(JAK)/Signal Transducer and Activator Transcription (STAT) pathway and play key 
roles as the physiological regulators of cytokine responses (Qin et al., 2012). Recently, 
the role of SOCSs has been investigated in murine macrophages. SOCS1, but not 
SOCS3, was induced rapidly in macrophages in response to stimulation with the anti-
inflammatory cytokines IL-4 and IL-13 in vitro. A similar induction was observed in  
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Table 1 Gene markers used in macrophage phenotyping in mammalian species 
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peritoneal macrophages following i.p. infection of mice with the parasitic nematode 
Brugia malayi (Briken and Mosser, 2011). 
    In SOCS1-knocked down mice, IL-4 failed to induce robust induction of arginase 
expression (Dickensheets et al., 2007). In addition macrophages from SOCS1 knockout 
mice also produced increased levels of TNF, IL-12, IFN-γ, and NO in response to 
stimulation with TLR-ligands (Briken and Mosser, 2011). Resting macrophages express 
low to undetectable levels of SOCS1, but the gene is induced rapidly following 
stimulation with IL-4/IL-13. SOCS-1 is also involved in the induction of arginase in M2 
macrophages. SOCS3 plays a crucial role in inhibiting STAT3 activation, cytokine 
signaling, and inflammatory gene expression in macrophages (Qin et al., 2012). 
Increased SOCS3 expression has been observed in LPS-and TNF-α-activated RAW 
264.7 mouse macrophages (Bode et al., 1999). Combined, these observations led to a 
key conclusion: that the ratio of SOCS1:SOCS3 is high in M2 macrophages and lower in 
M1 macrophages. SOCS1:SOCS3 ratio is therefore suggested to be a new indicator to 
identify M2 macrophages (Briken and Mosser, 2011).  
 
STAT1 vs. STAT3 
    In response to different stimuli, a network of signaling molecules, especially the 
STAT/SOCS signaling pathway, outline the different types of macrophage activation in 
the murine model. In macrophages displaying the M1 phenotype, expression of STAT1 
and IRF5 is up-regulated after exposure to IFNs and TLRs. The activation of STAT1 is 
crucial for inducing the production of cytokines [IL-12, IL-23, tumor necrosis factor 
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(TNF)] from M1 macrophages, which is involved in eliciting Th1 and Th17 responses 
(Krausgruber et al., 2011). In contrast, a predominance of STAT3 and STAT6 up-
regulation results in polarization to the M2 macrophage phenotype. STAT-mediated 
activation in macrophages is regulated by members of the SOCS family (Sica and 
Mantovani,  2012).  
 
iNOS / nitric oxide vs. arg / arginase 
    Nitric oxide (NO), an important regulator and mediator in many physiological and 
pathophysiological events, is produced by the oxidation of one of the guanidine 
nitrogens of L-arginine by a family of nitric oxide synthase (NOS) isoforms (Morris et 
al., 1998). When inducible nitric oxide synthase (iNOS) is induced in M1 macrophages, 
L-arginine will be converted into OH-arginine and then into NO. In contrast, M2 
macrophages express higher levels of arginase, which degrades L-arginine into urea and 
ornithine, which is then metabolized subsequently into proline and polyamines; these 
molecules contribute to collagen production and tissue repair (Classen et al., 2009). Both 
iNOS and arginase use intracellular L-arginine as substrate.  As a consequence, arginase 
can compete with iNOS and diminish NO production by reducing the availability of L-
arginine to iNOS (Chang et al., 1998).   
    The NOS expressed in macrophages can be induced by various pro-inflammatory 
cytokines, such as tumor necrosis-α (TNF-α), IL-1β, and IFN-γ, and by microbes or 
microbial membrane components such as lipopolysaccharide (LPS) and lipid A. Upon 
induction of iNOS, NO is produced continuously at a high rate in the presence of 
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adequate L-arginine supply. The availability of L-arginine is one of the rate-limiting 
factors in macrophage NO production (Chang et al., 1998). Production of NO has been 
implicated in several cytostatic and cytotoxic actions mediated by macrophages.  
    Arginase, another L-arginine consuming enzyme, coexists with iNOS in macrophages 
and is found to have high activity in the IL-4/IL-13- (anti-inflammatory cytokine) 
induced M2 phenotype (Mantovani et al., 2013). Arginase metabolizes arginine into urea 
and ornithine.  Arginase can be found in two isoforms, liver-type arginase I (Arg I) and 
non-hepatic type II (Arg II). Arginase I is located in the cytosol; while arginase II is 
located in the mitochondria. Both arginase isozymes can compete with iNOS and 
diminish NO production by reducing the availability of L-arginine to iNOS (Cecilio et 
al., 2011). Arg II and iNOS are upregulated early in LPS-induced mouse macrophages, 
while the Arg I isoenzyme is induced much later. In the mouse, Arg I and II mediate the 
production of L-ornithine, which can be decarboxylated by the enzyme L-ornithine 
aminodecarboxylase (ODC) to produce polyamines and contribute to regulation of cell 
growth. On the other hand, L-ornithine can also be converted into proline by L-ornithine 
amino-transferase (OAT), implicating Arg I and II in collagen production (Gordon, 
2003). Recently, Arg I, but not iNOS, was shown to be expressed in bone marrow-
derived macrophages submitted to M2 polarizing conditions. In contrast, M1 
macrophages expressed Arg II in addition to iNOS, but did not express Arg I (Khallou-
Laschet et al., 2010). The functions of Arg II include the production of ornithine and 
thus the production of proline and polyamines that are necessary for wound healing and 
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the formation of granulomas (Ash et al., 2000). Despite the progress in mammals, Arg I 
has unfortunately, not yet been identified or characterized in the chicken genome.  
 
Transferrin receptor vs. ferritin heavy chain 
    Iron is a key nutrient and a limiting factor of bacterial growth. Macrophages play a 
crucial role in body iron homeostasis by recovering iron from old red blood cells and 
returning it to circulation to bound to transferrin.  Transferrin then delivers the metal to 
cells which require iron for various functions, thus contributing to more than 80% of the 
daily iron turnover (Recalcati et al., 2010). Iron handling by macrophages has been 
shown to happen in opposite directions by M1 and M2 phenotypes. Iron retention in the 
reticulo-endoepithelial system is the main response to inflammation in terms of body 
iron homeostasis (Recalcati et al., 2010). Iron handling was recently suggested as one of 
the indicators of functional polarization of macrophages in mammals (Recalcati et al., 
2010). Ferritin heavy chain (FtH, an iron storage protein) and transferrin receptor (TfR, a 
mediator of iron uptake) both play important roles in the handling of iron by 
macrophages in mice. In M1 macrophages, the iron retention is increased by expanding 
the intracellular iron pool. The expansion is a means of increasing the iron uptake and 
delaying the iron export through expression of high levels of FtH and low levels of TfR 
(Corna et al., 2010). M1 macrophages also have limited ability to act as scavengers 
because they express lower levels of CD163 (Canton et al., 2013). Thus, M1 
macrophages limit the availability of iron in the circulation that could favor invading 
pathogens. By increasing expression of FtH and expanding their intracellular iron pool, 
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macrophages can protect themselves from oxidative damage (Kakhlon and Cabantchik, 
2002). In contrast, M2 macrophages lack the typical iron-withholding mechanism that is 
present in M1 macrophages.  Macrophages, which phagocytose senescent red blood cells, 
are the major contributors of iron required for erythropoiesis (Corna et al., 2010). M2 
macrophages, by contrast, are professional scavengers that express high levels of CD163 
(hemoglobin/haptoglobin receptor), enabling efficient iron re-uptake and recycling, a 
characteristic of M2 macrophages to promote iron release into the microenviroment 
(Gaetano et al., 2010).  
 
Ex vivo experimental model of macrophages: the peritoneal macrophage 
    The current fundamental knowledge regarding macrophage biology relies on the 
analysis of peritoneal macrophages, which have been widely used as a source of primary 
macrophages (Turchyn et al., 2007). In the murine model, the most commonly used 
technique for obtaining peritoneal macrophages is injecting mice with sterile Brewer’s 
thioglycolate broth (a mixture of salts, proteins, and growth factors used as bacterial 
growth medium), or with sterile 7.5% casein solution. A single injection of Brewer’s 
thioglycolate broth results in a mild inflammatory response, which is characterized by an 
influx of neutrophils during the first 4 to 12 hours, followed by increased numbers of 
elicited macrophages 24 to 90 hours post-injection (Turchyn et al., 2007). A growing 
body of evidence suggests that two functionally and phenotypically distinct subsets of 
macrophages (resident and elicited) co-exist in the abdominal cavity of mice upon 
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stimulation with inflammatory stimuli. Moreover, resident and elicited macrophages can 
be clearly distinguished by a series of different surface markers (Idoyaga et al., 2011).  
    Recent studies in mice indicate that resident peritoneal macrophages expressing M2 
phenotype scavenger receptors, such as SR-A1, act as scavengers for recognizing and 
taking up modified lipoproteins and apoptotic cells  (Canton et al., 2013; Platt and 
Gordon, 2001; Selvarajan et al., 2011). Elicited peritoneal macrophages express high 
levels of M1 phenotype receptors, such as MHC-II and co-stimulatory molecules 
including CD40, CD80, CD86, and CD54, upon inflammatory stimulation (Liu et al., 
2006; Liu et al., 2012). These cells also play a role in growth promotion by secreting 
growth factors such as vascular endothelial growth factor (VEGF), platelet-derived 
growth factor (PDGF), and transforming growth factor (TGF-β), able to rescue early 
apoptotic cells (Selvarajan et al., 2011). 
    In contrast to mice, chickens lack resident macrophages in their abdominal cavity. 
However, chicken macrophages can be recruited rapidly and extensively into the 
abdominal cavity if appropriate stimuli are applied (Klasing, 1998; Sabet et al., 1977). 
The most commonly used stimulus and technique for the avian model consists of 
injecting the bird intraperitoneally with 8 ml 3% (w/v) Sephadex G-50 in PBS and then 
harvesting elicited macrophages 42 hours post-injection by peritoneal lavage (Qureshi et 
al., 2000; Sabet et al., 1977). Chicken PEMs undergo functional maturation over time 
and can effectively bind, internalize, and degrade bacteria by lysosomal acid hydrolysis 
(Golemboski et al., 1990). Although Sephadex-elicited macrophages are considered to 
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be activated macrophages, they however require additional activation signals in order to 
acquire more specialized effector functions (Qureshi and Miller, 1991). 
    Chicken PEMs are the most commonly used macrophage subpopulation for studying 
avian macrophage biology; however, the features of macrophage polarization remain 
unclear in birds.  Next to the injection of Sephadex G-50, a biologically relevant event, 
internal ovulation, also elicits macrophage influx into the abdominal cavity for the 
purpose of clearing yolk particles (Nili and Kelly, 1996). Recently, the effects of 
intraperitoneally injected egg yolk on chicken blood monocyte-derived macrophages 
were investigated in vitro (Cornax et al., 2013). Egg yolk decreased the expression of 
pro-inflammatory cytokines and the production of NO by chicken macrophages (Cornax 
et al., 2013). This evidence suggests that exposure to egg yolk skews the macrophage 
phenotype towards M2, the functional phenotype of egg yolk-elicited macrophages and 
mechanism of their polarization is not entirely clear.  
 
Monoclonal antibodies against chicken macrophages 
   Few Mabs have been developed and used to study avian macrophage heterogeneity. 
(Trembicki et al., 1986) developed two Mabs (CMTD-1 and -2) which selectively 
reacted with chicken peritoneal exudate macrophages and splenic myeloid cells. 
Jeurissen et al. (1988) reported two Mabs, CVI-ChNL-68.1 and CVI-ChNL-74.2, 
reactive with chicken monocytes, macrophages, and interdigitating cells in tissue 
sections. Kaspers et al. (1993) described a Mab (K1) which detected chicken 
macrophages and thrombocytes. More recently, Mast et al. (1998) partially characterized 
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a Mab (KUL01) that positively cross-reacted with macrophage subpopulations in 
monocytes, macrophages, and interdigitating cells.  However, the exact epitope 
recognized by any of these Mabs remains unknown. Despite its cross-reactivity with 
other APCs, the anti-chCD40 Mab developed by our lab was shown to recognize and 
activate primary macrophages and cells from the chicken HD11 macrophage cell line 
(Chen et al., 2010b). 
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CHAPTER III  
A SINGLE DOSE OF A CD40-TARGETED IMMUNOGEN DELIVERED AT 
VARIOUS MUCOSAL INDUCTION SITES RESULTS IN ANTIGEN-SPECIFIC 
MUCOSAL SIGA AND CIRCULATING IGG PRODUCTION IN THE CHICKEN 
 
Introduction 
    Mucosal surfaces are vast surface areas that are the major portal of entrance of a wide 
range of pathogens. Therefore, the mediation of adaptive immunity at the mucosal sites 
is a key objective for improving avian health. Although the consequence of phylogenetic 
separation of chickens from the reptile ancestor of mammals was about 300 million 
years ago, chickens are also endowed with a sophisticated mucosal immune system 
including a series of redundant protective mechanisms (Smialek et al., 2011)  Chickens 
lack encapsulated lymph nodes such as are found in mammals, but rather possess diffuse 
lymphoid tissues (Muir et al., 2000). Mucosal immune responses are most efficiently 
induced when the antigen is delivered directly onto mucosal sites through mucosal 
routes (Woodrow et al., 2012). Mucosal immune sites are interconnected by a common 
mucosal immune system (CMIS) whereby stimulation of an inductive site (where the 
immune response initiated), the resulting immune response can be disseminated to the 
distal effector sites of the mucosa (Iwasaki, 2007). Vaccination has the great potential to 
be a vehicle to deliver antigen and induce an antigen-specific adaptive immune response 
in mucosal sites. However, direct mucosal immunization has been found to be difficult 
due to several factors including dilution of mucosal vaccines in the bulk of mucosal fluid 
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that limits absorption of antigen by the mucosal epithelium. Due to the complexity of 
mucosal surfaces, mucosal vaccines frequently fail to transverse the mucosal gel and are 
subsequently degraded by proteases (Neutra and Kozlowski, 2006; Woodrow et al., 
2012). 
    Several mucosal vaccines are universally used in poultry industry. However, most of 
these mucosal vaccines can only induce a local IgA immune response, and they are 
unable to react against the pathogen once it spreads through the circulation (Rauw et al., 
2010). Thus, a new formulation of vaccines that is capable of inducing both local 
mucosal and systemic immune responses is desired. The goal of any mucosal vaccine 
design is to increase immunogenicity (useful effector mechanisms) without leading to 
reactogenicity (inflammation, hypersensitivity, etc.). Among the various strategies under 
development, there is great potential for novel vaccines based on recombinant proteins 
and synthetic peptides. However, such antigens often lack the immunogenicity of live 
attenuated or whole killed pathogens used in traditional vaccines. There is, therefore, an 
urgent need to develop immunological adjuvants with a high potential to enhance 
immune responses (Barr et al., 2003) while simultaneously possessing a low potential of 
negative side effects. 
    A number of mucosal adjuvants for co-administration with live attenuated vaccines 
through the oculo-nasal or oral routes have been reported in chickens (Fingerut et al., 
2005; Girard et al., 1999; Linghua et al., 2007; Rauw et al., 2010). Despite the fact that 
these adjuvants do enhance mucosal sIgA and systemic IgG responses, they are still 
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considered time- and antigen-consuming since repeated injections of a large amount of 
antigen are still required.  
    In several studies, antigen-presenting cell (APC) targeting by antibodies directed 
against a co-stimulatory cell surface receptor, such as CD40, has been proposed as a 
promising strategy to induce specific systemic immunity in mammals (Barr et al., 2003; 
Hatzifoti and Heath, 2007). Recently, a study from our laboratory described that an anti-
chCD40 Mab-peptide complex targeted to APCs induces a rapid and robust systemic 
IgG response after a single subcutaneous (s.c.) injection (Chen et al., 2012). This result 
demonstrates the capacity of a CD40-targeted vaccine to rapidly induce a strong immune 
response, and, most importantly, the capability to induce a fast immunoglobulin class 
switch from IgM to IgG.  
    Complexes of anti-chCD40 and immunogen seem to show great potential as a 
potential vaccine platform in chickens, we were interested in assessing the effect of an 
anti-chCD40-peptide complex on mucosal immunogenicity. In this chapter, we test the 
hypothesis that a short synthetic peptide immuno-targeted to chCD40 can effectively 
target APCs of the MALT in vivo and induce an immunogen-specific sIgA response in 
the trachea and a specific IgG response in the circulation. We assessed mucosal and 
systemic antibody responses after a single administration via different mucosal routes, as 
compared to a classic s.c. injection.  Each time, the cCD40-specific peptide complex was 
compared to a “blind”, non-specific MIgG-peptide complex. 
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Materials and methods 
Anti-chCD40 monoclonal antibody (designated as 2C5) 
    Our lab has previous reported the development of an agonistic anti-chCD40 Mab, 
designated as 2C5 (Chen et al., 2010b). Mab 2C5 was made against the recombinant 
extracellular domain of chCD40 (chCD40ED), produced in collaboration with the lab of 
Dr. Mwangi (CVM-VTPB). This Mab recognized CD40 as expressed on primary 
chicken B-cells and macrophages, DT40 B-cells, and HD11 macrophages. Mab 2C5 also 
induced NO production in HD11 macrophages, and stimulated DT40 B-cell proliferation 
(Chen et al., 2010b). These results demonstrated that 2C5 induces downstream CD40 
signaling after binding to CD40 and is thus agonistic.  Mab 2C5 mimicked at the very 
least partially the functions of the chicken’s natural CD40 ligand, CD154.  Chen et al. 
(2012) also reported that targeting an antigen to chicken CD40
+
 APCs can significantly 
enhance antigen-specific circulatory IgG responses and thus induce fast immunoglobulin 
isotype-switching (Chen et al., 2012). 
 
Streptavidin-mediated complexing of peptide to mouse antibody 
    The anti-CD40 Mab-peptide complex (designated as “Mab 2C5-peptide complex”) 
and control complexes (where non-specific MIgG was substituted for anti-cCD40 Mab 
2C5) were prepared essentially as described previously (Chen et al., 2012). Briefly, anti-
chicken CD40 Mab 2C5 and non-specific control mouse immunoglobulin (MIg) were 
directionally biotinylated by derivatization of the carbohydrate moieties on the Fc 
fragment. Biotinylation and retention of chCD40-binding capacity were verified by 
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enzyme-linked immunosorbent assay (ELISA; results not shown). A synthetic amino-
terminally biotinylated peptide (b-NAWSKEYARGFAKTGK) and streptavidin (SA) 
were used in a stoichiometrically controlled complexing reaction of the biotinylated 
peptide with biotinylated 2C5 (or MIg) in a ratio of 1 SA molecule to 2 peptide 
molecules and 2 immunoglobulin molecules (Fig. 3).  
    However, because an immunoglobulin-peptide complex is likely susceptible to the 
enzymatic and acidic pH environment of the gastrointestinal tract, protective 
encapsulation of the immunoglobulin-peptide complex in an alginate matrix was 
considered a logical precaution when oral administration was required. Alginate 
encapsulation is a viable approach for oral delivery of antigens, and the entrapped 
functional immunoglobulin-peptide complex in fine alginate spheres can be safely 
delivered to the appropriate site, (such as the Peyer’s patches), despite the harsh 
gastrointestinal environment that would likely degrade any non-protected protein  (Desai 
and Schwendeman, 2013). For this study, encapsulation of Mab 2C5-peptide complex 
and MIg-peptide complex in alginate spheres was performed essentially as reported by 
Park and colleagues (Bowersock et al., 1999) with minor modifications. To prepare Mab 
2C5-peptide or non-specific MIg-peptide complex in the form of alginate-protected 
particles, the molecular complex was freshly produced and then gently mixed with 3% 
(w/v) sodium alginate (Sigma-Aldrich, St Louis, MO) in phosphate buffered saline 
(PBS), pH 7.4, to obtain a homogeneous solution. The resulting solution was then 
extruded drop-wise through a 23-gauge needle attached to a 1mL plastic syringe into 3% 
  
31 
 
(w/v) CaCl2 solution with gentle stirring for 30 minutes at room temperature. Gelified 
alginate spheres were separated from the CaCl2 solution by centrifugation at 3,000g for  
 
 
 
 
 
 
 
 
 
 
Figure 3 Preparation of antibody-peptide complex based on biotin-streptavidin 
interaction (Chen et al., 2012). Preparation of antibody-peptide complex based on 
biotin-streptavidin interaction. (I): Biotinylation was limited to the carbohydrate 
groups on the Fc region of MIg, hence did not interfere with antigen-antibody 
interaction. (II): Streptavidin (SA) was used for controlled complexing of biotinylated 
peptide with biotinylated MIg. Mab 2C5 in the 2C5-SA-peptide complex retained its 
biological function as demonstrated by ELISA (results not shown).  
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10 minutes at 4°C and were further washed three times with PBS, pH 7.4. To reduce the 
porosity of the alginate spheres, they were stabilized by coating them in 0.3% (w/v) 
poly-L-lysine solution with gentle stirring for 30 minutes at room temperature. Poly-L-
lysine coated alginate spheres were then washed three times with PBS, pH 7.4. These 
alginate spheres could be stored at 4
o
C until use. On the day of use, the alginate spheres 
were mechanically fragmented using an IKA® T10 basic ultra turrax homogenizer 
(Sigma-Aldrich) to form a suspension of smaller microspheres prior to oral 
administration of the suspension. The morphological characteristics of the alginate 
spheres were microscopically verified using a hemocytometer. The mean size of the 
alginate spheres prior to fragmentation was around 1.5mm in diameter, and the diameter 
of (fragmented) alginate microspheres in suspension ranged from 10 to 100μm.  
                             
Immunization of chickens with Mab 2C5-peptide complex in solution or as alginate-
encapsulated Mab 2C5-peptide complex microsphere suspension 
    Four-week old male Leghorns were randomly assigned to different groups 
(n=16/group). Non-encapsulated Mab 2C5-peptide complex (or “blind”, non-specific 
MIg-peptide complex, used as negative control) solution in PBS (pH=7.4), was used for 
immunization via subcutaneous (s.c.) injection, via cloacal drinking (bursal route), and 
via intraocular drop (oculo-nasal route) administration. For s.c. injection, 50μg Mab 
2C5-peptide / MIg-peptide complex in a volume of 0.5mL emulsified PBS (containing 
5% (v/v) squalene and 0.4% (v/v) Tween 80 (Sigma-Aldrich), pH=7.4) was injected in 
the nape of the neck of each chicken. For cloacal drinking, 50μg Mab 2C5-peptide / 
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MIg-peptide complex in a volume of 150μL PBS was administrated by dropping the 
immunogen solution onto the cloacal lips of chickens using a P200 pipette. For 
intraocular immunization, 50μg 2C5-peptide / MIg-peptide complex in a volume of 
40μL PBS was administrated as eye drops in both eyes of the chickens. For oral 
immunization with alginate sphere suspension, the immunogen was gently dropped into 
the oral cavity of the restrained chickens until they spontaneously swallowed it. Alginate 
suspension containing 50μg 2C5-peptide complex in a volume of 2mL PBS, pH 7.4, 
using a pasteur pipette was administered to each of the 16 chickens. Chickens that 
received the immunogen through cloacal or oral administration were fasted 24 hour prior 
immunization to prevent the immunogen from being regurgitated or expelled. The 
conditions for animal use in this study were approved by the Institutional Animal Care 
and Use Committee of Texas A&M University, in accordance with the guidelines of the 
American Association for Laboratory Animal Science. 
 
Quantification of peptide-specific serum IgG in by ELISA 
    Levels of peptide-specific IgG in circulation were determined by ELISA essentially as 
described previously (Chen et al., 2012). Briefly, biotin-peptide was first complexed 
with goat anti-biotin antibody (Thermo Scientific) on a rotator at 37
o
C for one hour in 
equimolar ratios. Next, the peptide-goat antibody complex (5μg/mL) was coated 
overnight on flat-bottom, 96-well microtiter plates (Thermo Scientific) in 0.05M 
carbonate-bicarbonate buffer, pH 9.6, at 4
o
C. Excess unadsorbed peptide-goat antibody 
complex was removed by rinsing the plates, and then they were blocked with PBS 
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containing 5% (w/v) bovine serum albumin (BSA) (Rockland Immunochemicals Inc., 
Gilbertsville, PA) for one hour at 37
o
C. Peptide coated wells were washed with PBS 
containing 0.2% (v/v) Tween 20 (SIGMA) (PBST) and then incubated with chicken 
serum samples diluted (1:100) in PBST containing 3% (w/v) BSA overnight at 4
o
C. The 
plates were then washed as described above and incubated with horseradish peroxidase-
conjugated rabbit anti-chicken IgY (H+L) (Thermo Scientific) diluted (1:12,000) in 
PBST containing 3% (w/v) BSA for one hour at room temperature. Isotype-specific 
rabbit anti-chicken IgY was used to avoid potential cross-reactions with IgM. The color 
reaction was developed using OptEIA™ TMB substrate (BD) according to 
manufacturer’s instructions. The reaction was terminated by addition of 1N sulfuric acid. 
Absorbances at 450 nm (A450) were measured in a Wallac plate reader (PerkinElmer 
Inc., Waltham, MA). The presence of peptide-specific IgG was determined by relating 
the mean A450 value of each serum sample to that of a positive control serum sample 
(diluted at 1:100), which was used as the internal standard on all plates, to allow 
comparison of titers across plates and experiments, but within isotype. The relative 
levels of peptide-specific IgG in all serum samples were determined and normalized by 
calculating the sample to positive (S/P) ratio as follows: S/P value = (Sample mean - 
negative control mean)/(Positive control serum mean - negative control mean). The 
effect of specifically targeting the peptide to cCD40 (as opposed to incorporating it in a 
non-specific antibody complex) was estimated by using the following calculation:  Mab 
2C5 (S/P) minus MIg (S/P). Student’s t-test was used to determine significant 
differences in means of S/P values between treatments across all groups, and S/P values 
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of the MIg-peptide complex group were used as baseline. All data were analyzed and 
generated using JMP® version 9 software (SAS Institute Inc., Cary, NC). Statistical 
significance was determined at P < 0.05.  
 
Quantification of peptide-specific tracheal sIgA by ELISA 
    Levels of peptide-specific sIgA in tracheal mucosa samples were determined by 
ELISA. Eight chickens from each group were sacrificed at either seven or 14 days post 
immunization (p.i.), and the tracheal mucosa sample from each chick was collected by 
preparing a tracheal wash as follows. In order to avoid blood contamination of the 
trachea, every chicken was euthanized using a CO2 chamber. The trachea was exposed 
aseptically at the pharyngeal region, and a 1-cm segment of trachea was collected, 
weighed, and then transferred to a 2-mL microcentrifuge tube. The trachea was 
suspended in cold PBST [137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 2mM KH2PO4, 
and 0.5% Tween 20 (v/v)] containing Halt
®
 Protease and Phosphatase Inhibitor (Thermo 
Fisher Scientific Inc., Barrington, IL), 0.1% (w/v) thimerosal, and 3% (w/v) BSA. To 
maximize the extraction efficiency of tracheal IgA, 1mL PBST was added per 100mg 
trachea sample weight. The tracheal mucosa was sloughed off from the inner liner of the 
trachea by vigorously vortexing for 30 seconds. The tube was centrifuged at 5,000xg for 
30 minutes at 4°C, and the supernatant was collected and frozen at -20
o
C until use. 
    The detection of sIgA in the mucosal extracts was performed as follows. Biotinylated 
peptide (b-NAWSKEYARGFAKTGK) was incubated with goat anti-biotin antibody 
(Thermo Fisher Scientific Inc.) on a rotator at 37
o
C for one hour. Flat-bottom, 96-well 
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microtiter plates (Thermo Fisher Scientific Inc.) were coated with peptide-goat antibody 
complex (5μg/mL) in 0.05M carbonate-bicarbonate buffer, pH 9.6 (SIGMA), overnight 
at 4
o
C. Excess peptide-goat antibody complex was removed, and plates were blocked 
with PBS, pH 7.4 containing 5% (w/v) bovine serum albumin (BSA) (Rockland 
Immunochemicals Inc., Gilbertsville, PA) overnight at 4
o
C. Peptide- coated wells were 
washed with PBST and then incubated with chicken tracheal IgA samples (diluted to 
1:100) in PBST containing 3% (w/v) BSA overnight at 4
o
C. The plates were then 
washed as described above and incubated with horseradish peroxidase-conjugated goat 
anti-chicken IgA (Thermo Fisher Scientific Inc.) diluted (1:10,000) in PBST containing 
3% (w/v) BSA for one hour at room temperature. Isotype-specific goat anti-chicken IgA 
was used to avoid the cross-reaction with other antibody isotypes. The color reaction 
was developed using OptEIA™ TMB substrate (BD, Lakes, NJ) per the manufacturer’s 
instructions, and terminated by addition of 1N sulfuric acid. Absorbances at 450nm 
(A450) were measured in a Wallac plate reader (PerkinElmer Inc., Waltham, MA). The 
presence of peptide-specific IgA was determined by relating the mean (A450)value of 
each tracheal IgA sample to that of a positive control IgA sample used as internal 
standard (1:100). The relative levels of peptide-specific IgA in all tracheal samples were 
determined and normalized by calculating the sample to positive (S/P) ratio as explained 
above for IgG. Student’s t-test was used to determine significant differences in means of 
S/P values between treatments across all groups, and S/P values of the MIg-peptide 
complex group were used as baseline. All data were analyzed and generated using JMP® 
  
37 
 
version 9 software (SAS Institute Inc., Cary, NC). Statistical significance was 
determined at P < 0.05.  
 
Results  
Antibody responses after a single parenteral (s.c.) immunization with anti-CD40-guided 
peptide complex vs. non-specific, “blind” peptide complex 
    To evaluate the effect of parenteral immunization of anti-CD40-guided Mab 2C5-
peptide complex on specific systemic and mucosal antibody responses, groups of five-
week old male Leghorns received a single s.c. immunization with 50 µg Mab 2C5-
peptide complex, and their responses were compared to those obtained with a “blind” 
non-specific MIg-peptide complex that served as the negative control. Trachea and 
plasma samples were collected from all immunized chickens at day 7 and 14 p.i., and 
peptide-specific IgA and IgG immune responses were assessed by ELISA.  As shown in 
Fig. 2A, a single s.c. injection of Mab 2C5-peptide complex induced peptide-specific 
circulatory IgG antibody responses that were significantly higher than those obtained 
with non-specific MIg-peptide controls at 7 (P<0.001)  and 14 days (P<0.001) p.i.. 
Peptide-specific sIgA immune responses were also significantly enhanced on day 7 
(P<0.001) and 14 (P<0.05) p.i. by targeting the immunogen to CD40 expressed on the 
chicken APCs (Fig. 2B). While we observed still statistically significant increased IgG 
and sIgA immune responses compared to controls on day 14 p.i., the major immune-
enhancement was clearly observed on day 7 p.i. The same effect can also be observed on 
the overview graph of all antibody responses shown in Fig. 4.  
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Figure 4. Levels of peptide-specific circulatory IgG in serum and mucosal sIgA in 
trachea. Levels of peptide-specific circulatory IgG (A) and mucosal IgA in trachea 
(B) elicited by a single s.c. injection of anti-cCD40-guided peptide complex (grey 
bars, as compared to non-specific MIgG-peptide complex, black bars) as 
determined by ELISA. Groups of eight five-week old male Leghorn chickens 
were subcutaneously immunized once with 50 μg Mab 2C5-peptide complex or 
negative control complex. In each case, error bars represent standard deviations 
from the mean and the asterisks represent statistical significance (n=8; *P<0.05; 
**P<0.01; ***P<0.001) compared with MIg-peptide complex controls as 
determined by Student’s t-test. At both time points, and for both antibody 
isotypes, a significant immune enhancement caused by CD40 targeting of the 
peptide cargo to the APCs was observed.  
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Antibody responses after a single mucosal immunization with anti-CD40-guided peptide 
complex vs. non-specific MIgG peptide complex             
    The potential immune-enhancing effect of the anti-CD40 Mab 2C5-peptide complex 
was also evaluated by administration of the immunogen via three different mucosal 
induction sites to the birds, each time using “blind” non-specific MIg-peptide complex 
as the negative control. Groups of five-week old male Leghorns were administrated a 
single Mab 2C5-peptide complex dose (50 μg) via one of the following mucosal routes: 
oculo-nasal (eye drops), cloacal-drinking (drops on the lips of the vent), and oral 
administration. The oral route was not administration by gavage into the stomach (which 
would bypass the esophagus and the crop) but active drinking of the immunogen 
solution. Trachea and plasma samples were collected 7 and 14 days p.i. and antibody 
responses were measured as described previously for the s.c. administration route. The 
results obtained from different mucosal routes of administration showed that 2C5-
peptide complex induced similar antibody response patterns of IgG (Fig. 5) and sIgA 
(Fig. 6) for each of the different routes. Antigen directly delivered to mucosal inductive 
sites via all three mucosal routes induced significant peptide-specific systemic IgG 
immune responses from days 7 p.i. (P<0.001) onward through day 14 p.i. (oculo-nasal: 
P<0.001; oral: P<0.01; cloacal-drinking: P<0.05) compared to MIg-peptide control (Fig. 
5). Fig. 6 shows that anti-CD40-guided Mab 2C5-peptide complex was also able to 
induce significant peptide specific sIgA responses through all three tested mucosal 
routes at days 7 p.i. (oculo-nasal: P<0.001; oral: P<0.01; cloacal-drinking: P<0.01) but 
those IgA responses clearly declined by day 14 p.i. (oculo-nasal: non-significant; oral: 
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P<0.01; cloacal-drinking: P<0.01) compared with MIg-peptide complex. Notably, 
mucosal administration of “blind” MIg-peptide complex through different routes also 
seemed to slightly numerically increase peptide-specific systemic IgG responses, and 
also the mucosal sIgA response but only after oculo-nasal administration.   
 
Calculation of the net immuno-enhancing effect of anti-CD40- targeting through 
different routes of administration 
    The above results allow us to assess the net immuno-enhancing effect of targeting a 
peptide to CD40
+
 APCs, as opposed to incorporation of the same peptide in a non-
specific, “blind” protein complex. For this purpose, the immuno-enhancing effect was 
defined as: [average (S/P) value of anti-CD40-guided complex) from which was 
subtracted [average (S/P) value of administration of”blind” complex].  This adjuvant 
effect was compared between administration routes (4) and time points (2).  
    As shown in Fig. 7A, s.c. administration of 2C5-peptide complex generated by far the 
most robust systemic IgG immune response achieved by CD40 targeting at day 7 p.i.. 
However, the level of magnitude of this enhancement was not sustained and declined to 
less than half of the original value by 14 p.i. (1.371 vs. 0.497). Although the net IgG 
effect of CD40 targeting through s.c. administration had declined by day 14 p.i., the net 
effect on systemic peptide-specific IgG levels was still higher than that obtained with 
any of the other mucosal routes, at any other time. The three mucosal administration 
routes posted similar but low net effect on systemic IgG responses at days 7 p.i. and 
moderately increased toward day 14 p.i. (Fig. 7A).  
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Figure 5. Levels of peptide-specific circulatory IgG in serum. Levels of peptide-specific circulatory IgG elicited by a 
single administration of anti-chCD40-guided peptide complex (gray bars, as compared to non-specific MIgG peptide 
complex, black bars) through oculo-nasal (A), cloacal drinking (B), and oral alginate suspension)(C) routes as 
determined by ELISA. Groups of eight five-week-old male Leghorn chickens were immunized once with either 50 μg 
anti-CD40-guided Mab 2C5-peptide complex or negative control MIgG-peptide complex via three different mucosal 
routes. Serum and trachea samples were collected 7 and 14 days p.i. and peptide-specific IgG responses were assessed 
by ELISA. In each case, error bars represent standard deviations from the mean and the asterisks represent statistical 
significance (n=8; *P<0.05; **P<0.01; ***P<0.001) compared with MIg-peptide complex controls as determined by 
Student’s t-test. 
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Figure 6. Levels of peptide-specific sIgA in trachea. Levels of peptide-specific mucosal sIgA elicited by a single 
administration of anti-chCD40-guided peptide complex (gray bars, as compared to non-specific peptide complex, black 
bars) through oculo-nasal (A), cloacal drinking (B), and alginate suspension (oral)(C) mucosal routes as determined by 
ELISA. Groups of eight five-week-old male Leghorn chickens were immunized once with 50 μg Mab 2C5-peptide 
complex or negative control complex via various mucosal routes and serum and trachea samples were collected from 
chickens at 7 and 14 days p.i. In each case, error bars represent standard deviations from the mean and the asterisks 
represent statistical significance (n=8; *P<0.05; **P<0.01; ***P<0.001) compared with MIg-peptide complex controls 
as determined by Student’s t-test. 
 
7 days                                        14 days 
7 days                                        14 days 
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    Surprisingly, s.c. immunization with 2C5-peptide complex induced a net effect of 
CD40 targeting on the secretion of peptide-specific IgA. The effect if the s.c. 
administration on specific IgA levels was similar in magnitude to that of the three 
different mucosal routes at day 7 p.i. (Fig. 7B). The net effect of CD40 targeting on 
peptide-specific IgA production had dropped substantially at day 14 p.i. in all routes of 
administration.  This could be partially the result of the fact that by day 14 p.i., the blind 
MIg-peptide complex started slowly inducing some peptide-specific sIgA immune 
response, which detracts from the net CD40-targeting effect of 2C5.   
 
Discussion              
    Agonistic monoclonal anti-CD40 antibodies have been demonstrated to be an 
effective immunological adjuvant in inducing specific systemic antibody responses in 
mammals through parenteral administration (Bartholdy et al., 2007; Li and Ravetch, 
2011). In our own lab, Chen et al, (2012) previously demonstrated that a single s.c. 
injection of anti-chCD40 Mab complexed with a synthetic peptide induced a specific, 
rapid and robust systemic IgG immune response, indicating an accelerating effect on 
immunoglobulin isotype switching of B-cells in chickens. However, for many pathogens, 
optimal protection seems to require both systemic and mucosal immune effectors 
(Neutra and Kozlowski, 2006).  
    Most immunization protocols for chickens have traditionally required intramuscular or 
subcutaneous injections (Dennehy et al., 1991; Knuf et al., 2010). These mostly induce a 
circulating IgM or IgG antibody immune response that often does not make any impact on the 
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Figure 7. The net effect of 2C5-peptide complex. The net effect of 2C5-
peptide complex on induced circulatory IgG (A) and mucosal sIgA (B) 
immune response through various mucosal and classic s.c. routes. The CD40 
targeting induced net effect was calculated as [Average (S/P) value of 
treatment from each route]-[Average (S/P) value of corresponding MIg 
control].  
A 
B 
  
45 
 
mucosal sites to be protected, due to (1) lack of isotype switching (to sIgA), (2) insufficient 
presence of blood-derived monomeric IgG or IgA on the apical cell surfaces, due to the 
lack of receptor-mediated transportation, or (3) inability of IgG or IgM to function in the 
external mucosal environment (Bowersock and Martin, 1999; Czerkinsky and Holmgren, 
2012).  
    In our current study, we have demonstrated that a single s.c. injection of anti-chCD40-
guided 2C5-peptide complex not only induces a rapid and strong systemic peptide-
specific IgG immune response, but also established a significant specific mucosal sIgA 
immune response, as measured in tracheal mucosal extracts. In the current study, the 
single s.c. injection with Mab 2C5-peptide complex induced significant systemic IgG 
responses on day 7 and 14 p.i., which is consistent with our previous study (Chen et al., 
2012), which focused on systemic IgG responses alone. It is tempting to consider that 
IgG secretion occurred even prior to day 7 p.i., but we did not sample on day 4 p.i., 
unlike in the previous study. Compared to conventional adjuvants, the anti cCD40 Mab 
2C5-peptide complex is able to mimic the biological role of CD4
+
 T cells by targeting 
APCs, including B-cells, and further enhancing CD40 downstream signaling and 
subsequent immunoglobulin class-switching from IgM to IgG.    
    Interestingly, a single s.c. injection with 2C5-peptiede complex also induced a 
significant mucosal peptide-specific sIgA immune response as early as 7 days p.i. as 
measured by ELISA in mucosal extracts from trachea segments. In the past, the most 
effective strategy to induce both systemic and mucosal immunity was by using a 
combination of priming and boosting through the mucosal and systemic routes, 
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respectively (Holmgren and Czerkinsky, 2005). To the best of our knowledge, past 
literature states that parenteral immunization alone is unable to prime the specific 
mucosal immune response in mammals because circulatory resting B-cells in the 
periphery express different homing receptors compared to the mucosal B-cells in the 
CMIS (Macpherson et al., 2008; Mei et al., 2009; Mestecky, 1987; Neutra and 
Kozlowski, 2006). However, this concept has recently been challenged, and a system 
similar to the CMIS has been proposed to explain that parenteral immunization might 
also contribute to antibody-mediated mucosal immunity in humans (Fernandes, 2012). 
Recently, activated B-cells were shown to express the mucosal homing receptor, 
chemoattractant cytokine receptor 10 (CCR10). CCR10
+
 B-cells in circulation are 
considered to be in transit between a systemic (peripheral) lymphoid tissue and mucosal 
effector tissues, where they are transformed into polymeric IgA-secreting plasma cells 
(Fernandes and Snider, 2010). Polyclonal anti-CD40 antibodies have been reported to 
initiate the CCR10 expression on recently activated memory B-cells in mice in vitro 
(Bernasconi et al., 2002). On the other hand, CCR10 ligand is expressed in all mucosal 
effector sites (Mora and von Andrian, 2008). In mammals, polyclonal anti-CD40 
antibodies were also reported to mediate the expression of CXCR4 on IgG-secreting B 
cells. CXCR4 is a homing receptor for homing of B-cells to the bone marrow and to 
secondary lymphoid organs, (Barr et al., 2005; Czerkinsky and Holmgren, 2012; 
Macpherson et al., 2008). We believe this provides a plausible mechanistic explanation 
for why parenteral immunization with 2C5-peptide complex may indeed be capable of 
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inducing both significant peptide-specific systemic IgG and mucosal sIgA immune 
responses. 
    Taking together, these results suggest that a single parenteral or mucosal 
immunization with an anti-cCD40 Mab guided antigen complex can induce not only a 
fast and long-lived systemic IgG immune response, but also a rapid local mucosal sIgA 
response. Therefore, this new platform may have the potential to be widely used for 
immunization of chickens through mucosal and/or parenteral administration in cases 
where both systemic and mucosal immunization is highly desirable. The latter is 
especially important for vaccination of poultry, in which most pathogens invade through 
the mucosal surfaces of the respiratory or digestive tract. Even though there are 
unresolved questions about the mechanism and the microenvironment of the interaction 
of APCs and anti-chCD40-peptide complex, the results obtained in the current study are 
encouraging, and there seems to be considerable potential for the development of safe, 
effective and affordable vaccines. While we have obtained convincing circumstantial 
evidence pointing towards enhanced clonal expansion of B- and T-cells as well as 
enhanced class-switching, an important immune parameter that remains to be studied is 
immunological memory (duration of protection), which, according to mammalian studies 
is also positively influenced  by CD40 signaling. 
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CHAPTER IV  
FUNCTIONAL PHENOTYPING OF CHICKEN PERITONEAL EXUDATE 
MACROPHAGES ELICITED WITH EITHER SEPHAROSE BEADS OR EGG YOLK 
PARTICLES 
 
Introduction 
    Mammalian macrophages are capable of displaying different phenotypes and can be 
polarized into two distinct phenotypic subtypes in response to microenvironmental 
queues: the “classical” (pro-inflammatory, M1) and the “alternative” (anti-inflammatory, 
M2) phenotype (Classen et al., 2009). M1 macrophages display antimicrobial activity 
while M2 macrophages typically act as scavengers. Diversity and plasticity are 
hallmarks of cells from monocyte-macrophage lineage. Until recently, phenotyping cells 
in the mononuclear phagocyte system, which includes macrophages and dendritic cells 
based on expression of cell surface markers such as CD11b, CD68, and F4/80, has been 
the mainstay of murine macrophage characterization (Murray and Wynn, 2011b). 
Murine polarized macrophages can be classified into either the M1 phenotype or the 
alternative M2 phenotype based on two criteria. Those criteria are (1) the specific stimuli 
that induce a particular phenotype, and (2) the cytokines secreted by the cells upon 
polarization. “M1 macrophage” refers to macrophages that have been exposed to Toll-
like receptor (TLR) ligands or interferon-γ (IFN-γ). These cells not only possess potent 
microbicidal properties through the production of NO and reactive oxygen intermediates, 
but also promotes strong Th1 responses through secretion of pro-inflammatory cytokines, 
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such as interleukin-1 (IL-1), Interferon (IFN)-γ, and IL-12. (Gordon, 2003). In contrast, 
M2 macrophages produce anti-inflammatory cytokines, such as IL-4/IL13 and IL-10, 
and are mainly associated with Th2 effector functions, including anti-parasitic activity 
and tissue repair through the production of polyamines and proline (Sica and Mantovani, 
2012). In mice M2 macrophages can be further divided into three functional 
subpopulations: M2a, (after exposure to IL-4/13), M2b (after exposure to immune 
complexes in combination with IL-1β or LPS), and M2c (induced by IL-10, tumor 
growth factor- β (TGF-β), or glucocorticoids) (Martinez et al., 2008). M2 also 
synthesizes arginase, an enzyme that inhibits NO production, allowing M2 macrophages  
to produce ornithine (a precursor of polyamines and proline) (Chang et al., 1998). 
Interestingly, although M1 and M2 macrophages display distinct phenotypes, the 
essential metabolic substrate that drives M1 and M2 macrophages through different 
pathways is identical: the amino acid L-arginine (Stempin et al., 2010).  
    In avian species, the immune-phenotypic polarization of avian primary macrophages 
has yet to be addressed in detail (He et al., 2011). In the past decade, a new way to 
identify macrophage phenotype based on gene expression profiles has been adopted in 
the murine model. In that model, M1 macrophage-associated genes have been 
thoroughly described, but relatively little is known about the functions of individual M2 
macrophage-associated genes. Recently, the fundamental knowledge of gene expression 
in M2 macrophages has rapidly increased  due to deletion studies of two M2 
macrophage effector genes, Arg1 and Retnla (Murray and Wynn, 2011a). Unfortunately, 
neither of these genes is known in the chicken.  
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    As shown in Table 1, various other genes appear to be preferentially expressed in 
either M1 or M2 mouse macrophages (M1 vs. M2: SOCS3 vs. SOCS1, iNOS vs. 
Arginase, STAT1 vs. STAT3, and FtH vs. TfR) (Briken and Mosser, 2011; Corna et al., 
2010; Sica and Mantovani, 2012; Whyte et al., 2011). Extension of these gene 
expression profiles to chicken macrophages would be particularly useful because most 
reliable markers for mammalian macrophages are not available for chicken macrophages. 
As a consequence, identifying chicken macrophage phenotypes is a challenge.  
    The current fundamental knowledge of mammalian macrophage biology relies mostly 
on the analysis of peritoneal macrophages, which have been widely used as a source of 
primary macrophages (Turchyn et al., 2007). A growing body of evidence suggests that 
two functionally and phenotypically distinct subsets of macrophages (resident vs. elicited) 
co-exist in the abdominal cavity of mice upon stimulation with inflammatory stimuli. 
Moreover, resident and elicited macrophages can be clearly distinguished by a series of 
different surface markers (Ghosn et al., 2010; Idoyaga et al., 2011).  
    In contrast to mice, chickens lack resident macrophages in their abdominal cavity. 
However, macrophages can be recruited rapidly and extensively into the abdominal 
cavity if appropriate stimuli are applied (Klasing, 1998; Sabet et al., 1977). The most 
commonly used stimulus and technique for the avian model consists of injecting 
chickens intraperitoneally with Sephadex G-50 (8 ml of 3% (w/v) Sepharose G-50 
suspension in PBS) and then harvesting elicited macrophages 42 hours post-injection by 
peritoneal lavage (Qureshi et al., 2000; Sabet et al., 1977). Chicken PEMs undergo 
functional maturation over time and can effectively bind, internalize, and degrade 
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bacteria by lysosomal acid hydrolysis (Golemboski et al., 1990). Although Sephadex-
elicited macrophages are considered activated, they require additional activation signals 
in order to acquire further specialized effector functions, such as anti-tumor activity 
(Qureshi and Miller, 1991).  
    Chicken elicited PEMs are the only abundant source of macrophages available for the 
study of avian macrophage biology and detailed features of macrophage polarization 
remain unclear. Next to the injection of Sephadex G-50, which is obviously an 
experimental manipulation, a biologically relevant event, i.e. internal ovulation, also 
elicits macrophage influx into the abdominal cavity for the purpose of clearing yolk 
particles (Nili and Kelly, 1996). Recently, the effects of intraperitoneally injections with 
egg yolk on chicken peripheral blood monocyte-derived macrophages were investigated 
in vitro (Cornax et al., 2013). Egg yolk was reported to decrease the expression of pro-
inflammatory cytokines and the production of NO by chicken monocyte-derived 
macrophages (Cornax et al., 2013). This partial phenotyping provides evidence showing 
that exposure to egg yolk skews the macrophage phenotype towards M2.  However, the 
details of the functional phenotype and the mechanism of macrophage polarization 
caused by egg yolk particles require further study.  
    Since elicited peritoneal macrophages provide the major source of cells for studying 
chicken macrophage biology, it is crucial to understand and characterize their functions 
and the mechanism of macrophage polarization following different eliciting stimuli 
(Sephadex G-50, vs. egg yolk). Utilizing functional assays and gene expression profiling 
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will hopefully help us better understand avian macrophage biology and potentially aid in 
the characterization of novel Mabs against Sepharose-elicited peritoneal macrophages.  
 
Experimental design 
    Our experiments were designed to test the hypothesis that avian macrophages can 
change their functional phenotype in response to micro-environmental influences. To 
determine the ex vivo levels of arginase enzymatic activity in S-PEMs and Y-PEMs, the 
arginase assay was performed immediately after PEMs were obtained from the 
peritoneal cavity of the bird and therefore were designated as “ex vivo”. Elicited PEMs 
were purified by plastic adherence (a protocol that takes several hours) were stimulated 
with LPS (5 µg/ml) for 8 hours. Since this stimulus was introduced several hours after 
the isolation and purification of the cells from the peritoneal cavity, this experimental 
treatment was designated as “in vitro”. After in vitro LPS stimulation, the functional 
phenotype of the cells was assessed using iNOS and (again) arginase enzymatic activity 
assays. Relative gene levels of eight of the most frequently cited genes in the context of 
macrophage polarization studies in mammals were measured in both ex vivo and in vitro 
groups using real-time PCR. The genes characteristic for M1 polarization included 
SOCS3, iNOS, STAT1, and FtH, while the genes pointing towards the M2 phenotype 
included SOCS1, arginase, STAT3 and TfR (see Table 1). Relative mRNA levels of 
arginase vs. iNOS ratio frequently used as an indicator of macrophage polarization and 
relative mRNA levels of SOCS1 to SOCS3 recently proposed as a new readout for 
macrophage polarization were also evaluated using real-time PCR. 
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Materials and methods 
Peritoneal exudate macrophage preparation 
    Peritoneal exudate macrophages were prepared according to previous publication with 
minor modifications (Cornax et al., 2013; Sabet et al., 1977). Female Leghorns were 
given a single intraperitoneal injection with 8 ml of 3% (w/v) Sephadex G-50 (Sigma) 
suspension in PBS or 5 ml of 50% (v/v) egg yolk in PBS with a 23-gauge needle. The 
optimum injection site was found to be: anatomical lower left, anterior-lateral, 
abdominal quadrant (i.e. 10 to 15 mm lateral to the mid-sagittal plane and 10 to 20 mm 
cephalad to the cloacal pore). Forty-two hours (Sephadex) or 30 hours (egg yolk) post 
injection (p.i.) the chickens were sacrificed, the peritoneal cavity opened, and the PECs 
were harvested by peritoneal lavage with 25 ml sterile PBS. Usually, 20 to 25 ml of cell 
suspension was harvested. The suspension was centrifuged at 270 x g for 10 min and the 
supernatant was discarded. The cell pellet was resuspended and carefully layered onto 
Histopaque-1077 (Sigma) in a 1:1 ratio, followed by centrifugation at 400 x g for 30 min 
at room temperature to separate the mononuclear cells. Peritoneal exudate macrophages 
(PEMs) were further purified by culture in a plastic flask for 4 h at 37˚C and 5% CO2. 
The non-adherent cells were removed by washing with warm RPMI1640 medium 
(Sigma). The adherent cells were detached and harvested with Accutase (Invitrogen; 
applied for 10 min at 37
o
C). The purity of the detached cells was evaluated by Giemsa 
stain. Over 90% of the plastic-adherent cells were morphologically identified as 
macrophages. Purified PEMs were then used in functional phenotyping and gene 
expression profiling assays. 
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Quantification of arginase enzymatic activity 
    To detect arginase enzyme activity in macrophages, the arginase assay was carried out 
according to previous published protocols (Chang et al., 1998). To detect arginase 
activity in both ex vivo and in vitro groups of S-PEMs and Y-PEMs, 3 x 10
6
 PEMs were 
rinsed with ice-cold DPBS twice, detached by incubation with commercially obtained 
Accutase solution (Invitrogen) at 37
o
C for 10 min, and then centrifuged at 250 x g for 5 
min. Cell pellets were resuspended in 200 µl lysis buffer (1 M Tris-Cl, pH=7.4, 5M 
NaCl, and 1% Triton X-100)  containing 1% (w/v) protease inhibitor (Sigma; P2714) at 
4
o
C for 2 h. Cell lysate was added to 50 µl of  Tris-HCl buffer (50 mM, pH=7.5) 
containing 10 mM MnCl2 and the mixture was incubated for 10 min at 55-60˚C to 
activate macrophage arginase. The hydrolysis reaction of L-arginine was carried out by 
incubating the cell lysate with 50 µl L-arginine (0.5M; pH=9.7) at 37 ˚C for 1 h. The 
reaction was stopped by adding 400 µl of an acid mixture consisting of H2SO4, H3PO4, 
and H2O in the ratio of 1:3:7. α-isonitrosopropiophenone [25 µl, 9%; dissolved in 100% 
ethanol (w/v)] was then added to the mixture, followed by heating to 100
o
C for 45 min. 
After the mixture was incubated in the dark for 10 min at room temperature, the urea 
concentration was determined spectrophotometrically by measuring the absorbance at 
550 nm with a Wallac plate reader (PerkinElmer Inc., Waltham, MA). The rate of urea 
production was used as an index for arginase enzymatic activity. 
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Detection of nitric oxide (NO) synthase enzymatic activity with the Griess assay 
    To detect the concentration of NO synthesized by chicken S-PEMs and Y-PEMs upon 
stimulation with LPS in vitro, chicken S- and Y-PEMs (1 x 10
6
) were cultured in a 24-
well cell culture plate in the presence or absence of LPS (5µg/ml; Sigma) in an 
atmosphere of 5% CO2 at 37 
o
C for 8 h. Nitrite concentration, a measure of NO synthesis, 
was assayed in 50 μL of culture supernatant using the Griess reagent essentially as 
previously described (Bingaman et al., 2000; Shoda et al., 2000; Shoda et al., 2001a; 
Shoda et al., 2001b). Briefly, 100 μL sulfanilamide solution [1% (w/v) sulfanilamide 
(Sigma) in 2.5% (v/v) phosphoric acid in MQ-water] was added to the supernatants, 
followed by addition of 100 μL naphthylethylenediamine dihydrochloride solution [0.1% 
(w/v) naphthylethylenediamine dihydrochloride (Sigma) in 2.5% (v/v) phosphoric acid 
in MQ-water)]. Absorbance at 550nm (A550) was measured and compared to that of a 
freshly prepared NaNO2 standard curve constructed to range from 0 to 160 μM. The 
mean micromolar concentration of nitrite was calculated from triplicate culture wells (± 
standard deviation). Differences in concentrations of accumulated nitrite were analyzed 
for statistical significance using the t-test.  
 
RNA extraction and reverse transcription 
    To determine the gene expression profile in S-PEMs, Y-PEMs, and their respective 
activated phenotypes, approximately 3 x 10
6
 PEMs were used. Total RNA extraction 
was performed using Trizol Reagent (Invitrogen, Carlsbad, CA) according to the 
manufacturer’s instructions. RNA yield was measured with a Nanodrop-1000 (Thermo 
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Scientific). The 260/280 absorption ratio was used as an estimate of RNA quality. 
Extracted RNA was stored at -80
o
C until used. Genomic DNA contamination was 
removed by incubation of the samples with DNase using the TURBO DNase Free kit 
(Invitrogen Carlsbad, CA). Reverse transcription was carried out on 100 ng of RNA with 
the SuperScript II reverse transcription kit (Invitrogen, Carlsbad, CA). 
 
Gene expression profile by quantitative Real-time PCR 
    Quantitative real-time analysis was performed on a 7500 Fast Real-time PCR System 
(Applied Biosystems). Genes and primers used in qPCR are shown in Table 2, RNA 
detection was performed using Power SYBR Green PCR Mastermix (Applied 
Bioscience). Most frequently used gene markers in mammals were assessed by 
quantitative real time PCR (Table 3). The 20 µl reaction mixture contained 10 µl SYBR 
PCR Mastermix, 1 µl cDNA, and 200 nmol/L of forward and reverse primers. The PCR 
cycle consisted of an initial 10 min denaturation step at 95˚C, followed by 40 cycles of 
denaturing (95˚C for 15 seconds) and annealing/extend (60˚C for 60 seconds). All the 
data were analyzed by Student’s t-test. P-values of less than 0.05 were considered 
significant. Quantification of the relative expression level of the gene of interest was 
performed according to the Livak method (Livak et al., 2001). All data were normalized 
to blood monocyte GAPDH Ct values. 
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Table 2. Primer sequences used in macrophage phenotyping 
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Table 3. Gene markers used in macrophage phenotyping in mammalian species 
 
 
 
 
 
 
 
 
 
 
 
 
 
   * The relative mRNA levels of several genes in S- and Y-PEMs were determined by  
      ∆∆Ct method. The fold change of each gene was expressed as a relative increase  
      or decrease compared to blood monocyte control.   
** The relative mRNA levels used for ratio calculation were determined by ∆Ct value.  
     The Ct value is inversely related to the actual mRNA values. A high Ct means a   
     low mRNA content. 
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Results and discussion 
Arginase activity in S- and Y- PEMs 
    Because arginase has been historically described as a typical M2 macrophage 
functional enzyme, we first examined the arginase activity in both sources of PEMs. As 
shown in Fig. 8, arginase activity is significantly higher in S-PEMs compared to the 
enzyme activity in Y-PEMs (P<0.01). No difference in arginase activity was observed 
between Y-PEMs and blood monocyte baseline expression control. After stimulation 
with the M1 stimulant LPS, arginase activity did not change significantly in either cell 
type (Fig. 8).  
    In mice, exposure of macrophages to M2-inducing stimuli induced high arginase 
expression levels (Gordon, 2003). The anti-inflammatory and scavenger properties make 
Y-PEMs an ideal model for M2 macrophage phenotype research (Cornax et al., 2013). 
Surprisingly, our results showed Y-PEMs contain less arginase activity than 
inflammatory chicken macrophage S-PEMs.  
    In mice, several reports indicate arginase activity can not only be up-regulated by Th2 
cytokines but also by various inflammation-inducing agents, such as casein and 
thioglycollate (Munder, 2009). The role of arginase in inflammation has been 
demonstrated by the fact that TLR-activated M1 macrophages also up-regulated their 
arginase activity by bypassing the IL-4 or IL-13 receptors and directly activating the 
arginase enhancer (El Kasmi et al., 2008; Louis et al., 1998).  Djeraba et al., (2002) also 
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reported arginase activity is not only up-regulated by TGF-β and PGE2, but M2-inducing 
stimuli. Arginase also appears to be up-regulated in LPS/IFN-γ-activated macrophages 
. 
 
 
 
 
 
 
 
Figure 8. Arginase activity in Sephadex- and egg yolk-elicited PEMs ex vivo 
and after in vitro LPS stimulation. Blood monocytes isolated from PBS-
injected chicken were used as baseline control. The results are expressed as 
mean ± SD (n=5; *** p<0.001, **p<0.01, *p<0.05).   
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in B
13
/B
13
 chickens, which are highly susceptible to Marek’s disease.  Thus, in the light 
of our data, we can conclude that using arginase activity as a “specific” marker for M2 
macrophage phenotyping in chicken remains somewhat controversial. Arginase activity 
is inducible and expressed at higher levels in M1 macrophage ex vivo in the chicken. 
 
Evaluation of NO producing capacity of Y- and S-PEMs after stimulation with LPS 
    As shown in Fig. 9, LPS-activated S-PEMs produced significantly higher levels of 
NO (P<0.05) compared to LPS-activated Y-PEMs. Vigorous production of NO after 
stimulation with LPS/IFN-γ is the hallmark of M1 macrophages (Classen et al., 2009). 
The formation of NO is also associated with the ability of macrophages to deplete tumor 
cells of iron-sulfur prosthetic groups (Qureshi et al., 2000). This finding is consistent 
with the previous report by Cornax et al. (2013) that exposure to egg yolk limited 
macrophage NO production. This suggests egg yolk may indeed down-regulate mRNA 
expression of pro-inflammatory cytokines  (such as IL-1, IL-8, and IFN-γ) in chicken 
macrophages in vitro (Cornax et al., 2013). Our results (Fig. 9) indicate that both NO 
production (iNOS activity) and arginase activity were higher in S-PEM inflammatory-
type macrophages in the chicken. In our hypothesis, chicken S-PEMs and Y-PEMs 
polarize towards the M1 and M2 phenotype, respectively 
    Based on NO production patterns we can still conclude that S-PEMs are M1 
macrophages and that Y-PEMs are more likely shifted to the M2 phenotype, despite the 
apparent conflict on chicken macrophage arginase activity with the murine model. 
Currently, very little is known about arginase activity in chicken macrophages. The 
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regulation of arginase in chicken macrophages is still under debate and may indeed be 
different than in murine macrophages. (Djeraba et al., 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
Figure 9. NO production by ex vivo and in vitro LPS-stimulated Sephadex- 
and egg yolk-elicited PEMs. Monocytes isolated from PBS-injected chicken 
used as baseline control. The results are expressed as mean ± SD (n=5; *** 
p<0.001, **p<0.01, *p<0.05). 
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Gene expression profiles in S-PEMs and Y-PEMs, ex vivo or after in vitro LPS 
stimulation  
Comparison of Arg II and iNOS mRNA expression  
    In ex vivo preparations, LPS stimulation down-regulated Arg II and but up-regulated 
iNOS mRNA expression in S-PEMs, (-2.985 ± 0.409 vs. 2.544 ± 1.064 fold change, 
respectively), both when compared with blood monocytes. In contrast, in ex vivo Y-
PEMs, the mRNA expression of Arg II and iNOS mRNA expression (-5.258 ± 4.653 vs. 
-7.554 ± 1.994 fold change, respectively) were both down-regulated. Arg II gene 
expression did not show statistically significant differences between S- and Y-PEMs. 
However, iNOS mRNA expression was significantly higher in ex vivo S-PEMs than in 
ex vivo Y-PEMs (P<0.05, Table 4 and 5). In vitro LPS stimulation resulted in Arg II 
mRNA expression being up-regulated in both S- and Y-PEMs. The increased mRNA 
expression did not reflect the functional enzyme activity levels observed in both types of 
PEMs, which were not influenced by LPS stimulation (Fig. 8). 
    Arginase and iNOS mRNA expression are the most commonly used indicators in 
macrophage functional phenotyping in mice (Chiang et al., 2008). The mRNA 
expression of Arg II and iNOS in avian S-PEMs is consistent with observations in M1 
macrophages in mice (Mullner et al., 2002). The down-regulation of iNOS mRNA levels 
in ex vivo Y-PEMs is expected and consistent with our results of NO production in the 
previous functional assay. Egg yolk is an anti-inflammatory immunostimulant by nature 
(Cornax et al., 2013). Walzem et al. (1994) and others demonstrated egg yolk is 
phagocytosed by chicken macrophages (probably through scavenger receptors) and gets  
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Table 4. Relative mRNA expression of iNOS and Arg II (fold change) in ex vivo and in 
vitro LPS-stimulated Sephadex and egg yolk elicited PEMs. 
a. All data normalized to blood monocyte control Ct values. The results are 
expressed as mean ± SD (n=3) 
a. n=3; NS: non-significant, *** p<0.001, **p<0.01, *p<0.05. 
Table 5. Comparison of gene expression profiles in ex vivo and in vitro LPS-stimulated 
macrophages.   
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repackaged into novel lipoproteins for secretion into blood stream (Barron et al., 1999; 
Walzem et al., 1994). Egg yolk also inhibited LPS-induced mRNA expression of pro-
inflammatory cytokines (IL-1, IL-8, and IFN-γ), while leaving IL-10 expression 
unchanged in chicken macrophages in vitro. As previously mentioned, egg yolk 
inhibited LPS-induced NO production by reducing mRNA expression. The anti-
inflammatory effect of yolk was suggested to potentially be mediated by carotenoid 
(Cornax et al., 2013); however, the underlying mechanism is still unclear. 
    Furthermore, the composition of egg yolk is complicated. One of the components, 
modified lipoprotein, induced Arg I but not Arg II mRNA expression in mouse 
macrophages; this effect is mediated by peroxisome proliferator-activated receptor 
(PPAR) (Gallardo-Soler et al., 2008). This indicates the expression of Arg II may not be 
affected by egg yolk and contribute to the baseline expression of arginase. Arg II mRNA 
expression can be induced by LPS in the murine model, which is consistent with our 
results (Morris et al., 1998). 
 
The value of the Arg II /iNOS ΔCt ratio as a phenotypic macrophage marker  
    In this study, the ratio of Arg II to iNOS mRNA levels was determined based on the 
ΔCt value of each gene as normalized to GAPDH. A higher value for the Arg II/iNOS 
ΔCt ratio points toward an M1 polarized macrophage phenotype.  In this study, the Arg 
II/iNOS ΔCt ratio was shown to be significantly higher (P<0.05) in ex vivo S-PEMs 
compared to both Y-PEMs and blood monocytes (1.661 vs. 1.077 and 0.994) with no 
significant differences between Y-PEMs and blood monocytes (Fig. 10). After LPS  
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stimulation in vitro, the Arg II/iNOS ΔCt ratio significantly increased (P<0.01) in Y-
PEMs (2.549), and a numerical but statistically non-significant increase was observed in 
S-PEMs (Fig. 10). 
    As mentioned above, the Arg II/iNOS ΔCt ratio is often used as a functional indicator 
for determining macrophage phenotypes. In our experiments, the Arg II/iNOS ΔCt ratio 
indicates ex vivo S-PEM phenotype was shifted towards M1. However, after in vitro LPS 
activation, the Arg II/iNOS ΔCt ratio was no longer different between S-PEMs and Y-
PEMs, indicating that chicken macrophages indeed have the capacity to change their 
phenotype in response to the microenvironmental queues they are exposed to in vitro. 
Therefore, with regard to phenotypic plasticity, avian macrophages are similar to their 
mammalian counterparts (Stout et al., 2005). 
 
Ferritin Heavy chain (FtH) mRNA vs. Transferrin Receptor (TfR) mRNA 
    In our study, the level of FtH mRNA expression was shown to be significantly higher 
(P<0.05, Table 6) in ex vivo S-PEMs than ex vivo Y-PEMs (14.597 ± 4.015 vs. 3.101 ± 
2.204)(Table 6). On the other hand, TfR mRNA expression was slightly up-regulated in 
ex vivo S-PEMs (compared to blood monocyte controls), but down-regulated in Y-PEMs 
(P<0.05, 1.569 ± 0.368 vs. -3.979 ± 1.84) (Table 6 and 7). After LPS activation in vitro, 
FtH mRNA expression in both sources of PEMs was down-regulated compared to the 
control blood monocytes (-4.798 ± 1.023 vs. -1.728 ± 0.484)(Table 7). TfR mRNA  
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Figure 10. The Arg II/iNOS ∆Ct ratio in ex vivo and in vitro LPS-
stimulated  Sephadex- and egg yolk-elicited PEMs.  Blood monocytes 
isolated from PBS-injected chicken used as baseline  control. The 
results are expressed as mean ± SD (n=3; *** p<0.001, **p<0.01, 
*p<0.05). 
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Table 6. Relative mRNA expression of FtH and TfR (fold change) in ex vivo and in 
vitro LPS-stimulated Sephadex and egg yolk elicited PEMs. 
Table 7. Comparison of gene expression profiles in ex vivo and in vitro LPS-stimulated 
macrophages.   
a. All data normalized to blood monocyte control Ct values. The results are expressed 
as mean ± SD (n=3) 
a. n=3; NS: non-significant, *** p<0.001, **p<0.01, *p<0.05. 
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expression in both sources of cells was up-regulated (8.451 ± 1.687 vs 4.470 ± 
0.672)(Table 7). 
    Iron is a key nutrient and limiting factor of bacterial growth (Corna et al., 2010). Iron 
handling was recently suggested as one of the indicators of functional polarization of 
macrophages in mammals (Recalcati et al., 2010). FtH and TfR play opposite roles in 
the handling iron by macrophages and have been described as novel indicators of 
macrophage polarization in murine models (Corna et al., 2010; Recalcati et al., 2010). 
M1 macrophages limit the availability of iron in circulation which could deter invading 
pathogens. In contrast, M2 macrophages lack the typical iron-withholding mechanism 
present in M1 macrophages (Kakhlon and Cabantchik, 2002).   
    The gene expression patterns of FtH and TfR in S-PEMs ex vivo are consistent with 
the M1 phenotype in mice in vitro (Corna et al., 2010). The results suggest that 
Sephadex recruits blood monocytes to enter the peritoneal cavity; they become S-PEMs 
and undergo functional maturation into inflammatory type macrophages. In previous 
studies, S-PEMs showed an increased expression of TfR on their cell surface throughout 
the maturation process inside the peritoneal cavity in vivo (Golemboski et al., 1990). 
This could explain the slightly increased TfR mRNA expression immediately after 
purification in S-PEMs (42 hours p.i. of Sepharose). The strongly elevated levels of 
mRNA expression of FtH (an almost a 15-fold upregulation of FtH mRNA was observed) 
indicate the S-PEMs harvested in our studies displayed a phenotype skewed towards M1 
in order to increase their Fe withholding capacity from the microenvironment. 
Furthermore, a reduction of iron in the circulation was also shown to activate T-cell- 
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dependent antimicrobial adaptive immunity, favoring the shift towards Th1 responses 
(Mencacci et al., 1997; Omara and Blakley, 1994). 
    In the current study, ex vivo Y-PEMs expressed high levels of FtH (3-fold up-
regulation) but low levels of TfR (3-fold down-regulation). The relatively high ex vivo 
expression of TfR mRNA in Y-PEMs was phenotypically opposite to what was observed 
in murine M2 gene expression in vitro in mammals (Recalcati et al., 2010). TfR is a 
carrier protein needed for transport of iron into macrophages and is regulated by 
intracellular iron concentration. Low iron concentrations induce increased levels of TfR 
to increase iron intake into the cells. Cornax et al. (2013) observed that egg yolk 
increased plasma iron concentrations greatly, because of the rich source of 
phosphoprotein-bound iron (Cornax et al., 2013). This could be a reason that TfR 
mRNA expression levels did not increase in Y-PEMs. The concentration of iron in the 
milieu could be an important factor controlling the expression of TfR mRNA.  
    In mice, stimulation of macrophages with IFN-γ/LPS activates the iron regulatory 
binding proteins (IRP)-1 and -2, which then inhibits translation of the FtH protein 
(Weiss et al., 1997). In the current study, both S- and Y-PEMs may secrete IFN-γ in 
vitro, and may be regulated in an autocrine fashion in response to the plastic adherence, 
in synergy with the added LPS stimulus which further inhibits FtH mRNA expression.  
 
Gene expression of STAT1 vs. STAT3 and SOCS1 vs. SOCS3  
   So far, in this comparative analysis of avian and mammalian macrophages, clear 
parallels between both systems have been observed. However (as shown in Table 8 and 
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9) in the postulated avian M2 equivalent, ex vivo Y-PEMs, SOCS1, and its upstream 
regulator, STAT3, clearly don’t behave as their mammalian (M2) counterparts. The 
mRNA expression of SOCS1 was down-regulated in both ex vivo sources of PEMs, but 
this effect was dramatic in ex vivo Y-PEMs (-22 fold) compared to blood monocytes 
(Table 10). Similarly, STAT3 was also down-regulated (-7 fold) in ex vivo Y-PEMs 
(Tables 9 and 10). These discrepancies could result from the differences between species, 
as seems to be the case in our analysis of arginase activity (Fig. 8). The divergence may 
simply be the consequence of phylogenetic separation of chickens from mammals about 
300 million years ago (Furlong, 2005).  
 
 
 
 
   
Table 8. Diagrammatic comparison of the gene expression of SOCS1, SOCS3, STAT1, 
and STAT3 in mice and our current ex vivo chicken macrophage models. 
       : no change;      : down-regulate;     : up-regulate. Arrows in red indicate the 
genes behave differently between mice and chicken.    

 
 
  
72 
 
 
 
 
 
 
 
 
 
 
Table 9. Relative mRNA expression of SOCS1, SOCS3, STAT1, and STAT3 (fold 
change) in ex vivo and in vitro LPS-stimulated Sephadex- and egg yolk-elicited PEMs. 
a. All data normalized to blood monocyte control Ct values. The results are 
expressed as mean ± SD (n=3) 
Table 10. Comparison of gene expression profiles in ex vivo and in vitro LPS-stimulated 
macrophages.   
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    However, methodological aspects may also help explain the contrast. As previously 
mentioned, the plastic adherence purification process (which lasts 4 hours) may induce 
macrophage secretion of pro-inflammatory cytokines such as IL-1, IFN-γ, and TNF-α in 
an autocrine fashion (Chiang et al., 2008). This secretion could result in the inhibitory 
effect on SOCS1/STAT3 signaling (Bode et al., 1999). Our results indicate that mRNA 
expression of SOCS1/STAT3 in avian macrophages does behave differently compared 
with mouse macrophages.      
 
The value of the SOCS1/SOCS3 ΔCt ratio as a phenotypic macrophage marker     
     In the previous section, the ex vivo SOCS1 and SOCS3 mRNA expression was 
demonstrated to behave differently in chickens than in mice. In mice, the M1 
macrophage expresses a higher SOCS1/SOCS3 ∆Ct ratio than M2 macrophages. 
However, as shown in Fig. 11, the SOCS1/SOCS3 ∆Ct ratio was significantly higher in 
ex vivo Y-PEMs (P<0.05) than in ex vivo S-PEMs and blood monocytes, respectively. S-
PEMs showed a similar SOCS1/SOCS3 ∆Ct ratio as blood monocytes. After stimulation 
with LPS for 8 h in vitro, SOCS1/SOCS3 ∆Ct ratio decreased in Y-PEMs, while the 
value of this parameter would be expected to increase after an inflammatory stimulus. 
However, it showed no differences with control blood monocytes.  
    In murine M2 macrophages, IL-4 induced SOCS1 up-regulation and subsequent 
expression of arginase. However, we have demonstrated that chicken arginase activity 
does not behave as in the murine model. In this study, SOCS1/SOCS3 ∆Ct ratio 
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expression in S- and Y-PEMs was also different compared to mammals, indicating the 
SOCS ratio cannot be used as a marker of avian macrophage phenotype.      
             
 
 
 
 
 
 
Figure 11. Expression of SOCS1/SOCS3 ∆Ct ratio in ex vivo and in vitro 
LPS-stimulated Sephadex- and egg yolk-elicited PEMs.  Monocytes 
isolated from PBS-injected chickens were used as baseline  control. The 
results are expressed as mean ± SD (n=3; *** p<0.001, **p<0.01, 
*p<0.05). 
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Conclusion     
    mRNA expression analyses in elicited chicken PEMs ex vivo in this study has led to 
somewhat contradictory conclusions when compared with in vitro polarized murine 
macrophage models. The contradictory gene expression profiles in our two PEMs 
models, especially in Y-PEMs, may partly result from the methodology used to 
manipulate the Y-PEMs prior to the mRNA assay procedure, more specifically from the 
plastic adherence purification step.  
    Peritoneal exudate cells contain several cell types. In order to enrich the macrophage 
subpopulation from the exudate, the macrophages were allowed to attach to a plastic 
surface for several hours, a procedure that is commonly used for this purpose. However, 
attachment is a priming event for macrophages and thus the gene expression profile 
could be altered in attached macrophages. This issue has also been reported in the 
murine models (Krause et al., 1996). The mere adherence of monocyte and macrophage 
to a plastic tissue culture flask could induce expression of a multitude of genes and 
silence the production of others (Stout et al., 2005). Chiang et al. (2008) reported 
peritoneal resident macrophages purified by the adherence method showed significant 
induction of TNF-α, IL-1α, IL-1β, IL-6, and IFN-γ mRNA expression compared with in 
vivo LPS-activated peritoneal macrophages in murine models.  
    Chicken Sephadex G-50 elicited peritoneal macrophages represent an inflammatory 
macrophage population that is highly phagocytic and bactericidal (Qureshi et al., 2000). 
In combination with a strong pro-inflammatory stimulant, S-PEMs can be further 
activated and are capable of killing tumor cells (Qureshi et al., 2003). This priming 
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effect might not have been very critical for M1 macrophages in our studies. However, 
the priming effects of plastic adherence may have masked the anti-inflammatory effect 
of egg yolk, especially with regard to the expression of the SOCS/STAT axis in Y-PEMs. 
In M2 macrophages, the SOCS1/STAT3 axis is dominantly expressed but can be 
inhibited by IFN-γ (Sachithanandan et al., 2011). The adherence to a plastic surface 
induces IFN-γ production in macrophages, which then becomes an autocrine pro-
inflammatory stimulus. This may have altered the expression of SOCS1/STAT3 pathway 
in Y-PEMs.  
    We have demonstrated that some well-defined mammalian macrophage phenotype 
markers were not recapitulated in chicken macrophages. We found that the arginase 
activity appeared to be higher than expected in S-PEM inflammatory type macrophages 
compared to the situation in mammals. In addition, some of the gene expression markers 
related to cytokine inhibition and activation were likely altered by the adherence 
purification procedure, especially in the presumed avian M2 equivalent, the Y-PEMs. 
For example, the SOCS1/SOCS3 mRNA ratio was expected to be high in Y-PEMs, the 
proposed equivalent of M2 macrophages. However, our results revealed the opposite, 
suggesting that a simple adhesion purification step may alter or mask responses. This 
observation suggests that despite the risks of contamination with other cell types, the 
best way to characterize chicken PEM phenotype might be to directly assay the cells ex 
vivo, immediately following isolation, thus without prior purification.  
    Taken together, our results clearly suggest Sephadex elicitation skews the phenotype 
of avian macrophages to the M1 side. In contrast, despite the conflicting gene expression 
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profiles, we can still conclude that egg yolk elicitation shifts the avian macrophage 
phenotype towards the M2 pole, especially when taking into account the low level of 
iNOS mRNA expression.  
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CHAPTER V  
DEVELOPMENT AND CHARACTERIZATION OF NOVEL ANTIBODIES 
AGAINST CHICKEN PERITONEAL EXUDATE MACROPHAGES 
 
Introduction 
    The mononuclear phagocyte system (MPS) plays a critical role in host defense and is 
defined as a group of cells that arises from hematopoietic progenitors in the bone 
marrow; it consists of circulating blood monocytes and resident tissue macrophages in 
most of the organs in the body.  Macrophages are a heterogeneous group of cells and 
their subpopulations are polarized depending on the microenvironment from which they 
were exposed. Until recently, characterization of the differentiation and heterogeneity of 
macrophages was still defined based on the expression of cell surface markers (such as 
CD11b, CD68, and F4/80) (Murray and Wynn, 2011a). Specific monoclonal antibodies 
(Mabs) against cell surface markers have great potential for use in this type of 
application.  
    The study of avian macrophages was and still is delayed compared to their 
mammalian counterparts due to two reasons: (1) relatively few chicken macrophage-
specific surface markers have been identified and commercialized, and (2) chickens lack 
the significant number of harvestable resident macrophages that are commonly used in 
mammalian species.  In 1977, an avian macrophage model system was developed that 
allowed the isolation of elicited peritoneal macrophages following injection of 
Sepharose beads (Sabet et al., 1977). This avian macrophage model has been used as the 
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main source of primary chicken macrophages to this day. These elicited chicken 
peritoneal exudate macrophages (PEMs) are considered to be “primed” macrophages 
that are already capable of certain activated macrophage functions, such as bacterial 
killing (Qureshi and Miller, 1991). Sephadex-elicited PEMs (S-PEMs) display 
characteristics of an increasingly activated state as a function of time after the Sepharose 
injection into the peritoneal cavity, and can effectively bind, internalize, and degrade 
bacteria by lysosomal acid hydrolysis (Golemboski et al., 1990). Although Sephadex-
elicited macrophages are considered activated, they still require additional activation 
signals in order to acquire more specialized effector functions (Qureshi and Miller, 
1991).  
    In the murine macrophage model, two co-existing but physically, functionally, and 
developmentally distinct subpopulations of peritoneal macrophages have recently been 
identified. Furthermore, in the mouse, peritoneal exudate macrophages have been shown 
to express CD62L (L-Selectin), which supports the idea that peritoneal exudate 
macrophages may migrate to peripheral lymph nodes and serve as antigen-presenting 
cells (APCs) if the appropriate stimuli are applied (Idoyaga et al., 2011). Antigen-
presenting cells (including dendritic cells [DCs], B-cells, and macrophages) are the 
bridge between innate and adaptive immunity and are therefore of particular interest to 
our lab.               
    Few Mabs have been developed and used to study the heterogeneity of avian 
macrophages. Trembicki et al. (1986) developed two Mabs (CMTD-1 and -2) that 
selectively reacted with chicken peritoneal exudate macrophages and splenic myeloid 
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cells, respectively (Trembicki et al., 1986). Jeurissen et al. (1988) reported a Mab 
reactive with chicken monocytes, macrophages, and interdigitating cells (Jeurissen et al., 
1988). Kaspers et al. (1993) described a Mab which detected chicken macrophages and 
thrombocytes (Kaspers et al., 1993). More recently, Mast et al. (1998) reported a Mab 
that cross-reacted with chicken macrophage subpopulations of monocytes, macrophages, 
and interdigitating cells (Mast et al., 1998). However, the exact epitope or antigen 
(Cluster of Differentiation) recognized by these Mabs still remains unknown, and their 
purported specificity is based on empirical and circumstantial evidence.  
    Recently, a study from our lab described an anti-chicken CD40 Mab  that when 
complexed with a synthetic peptide, targets APCs and helps induce a rapid and robust 
systemic IgG response after a single subcutaneous (s.c.) injection (Chen et al., 2012). 
These results indicate Mabs against cell surface receptors can be used to both 
characterize cell heterogeneity and provide the potential to develop novel immunization 
strategies.  
    Ideally, our next target for Mab production would have been chicken CD11c or 
CD205, because both receptors have been reported as useful targets for in vivo 
immunogen targeting in mammals (Birkholz et al., 2010; Tel et al., 2011).  However, the 
chicken ortholog for CD11c has not been identified in the chicken genome, and repeated 
efforts to make antibodies against CD205 have failed due to a lack of a suitable 
immunogen (results not shown). Therefore, we decided to use primary chicken 
macrophages as our immunogen and to attempt to identify the cognate antigens of any 
resulting Mabs post facto. In this study, we raised three new Mabs against cell receptors 
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expressed on Sephadex-elicited chicken peritoneal macrophages and defined the linear 
epitope recognized by one of these new Mab by using peptide phage display technology. 
 
Materials and methods 
Immunogen preparation  
    Peritoneal exudate macrophages were prepared in essence according to previous 
publication with minor modifications (Sabet et al., 1977). Briefly, female Leghorns were 
given a single intraperitoneal injection with 8 ml of a 3% Sephadex G-50 suspension in 
PBS with a 23 gauge needle. The optimum injection site was found to be in the 
anatomical lower left, anterior-lateral, abdominal quadrant (i.e. 10 to 15 mm lateral to 
the midsagittal plane and 10 to 20 mm cephalad to the cloacal pore).  Forty-two hours 
post injection chickens were sacrificed, the peritoneal cavity opened, and the peritoneal 
exudate cells (PECs) were harvested by peritoneal lavage with 25 ml sterile PBS.     
Usually, 20 to 25 ml of cell suspension was harvested. The suspension was centrifuged 
at 400 x g for 10 min at 4 ˚C and the supernatant was discarded.  The cell pellet was 
resuspended in 3 ml PBS and carefully layered onto Histopaque-1077 (Sigma) in a 1:1 
ratio. The cells were then centrifuged at 400 x g for 30 min at room temperature to 
separate mononuclear cells from the PECs. Peritoneal exudate macrophages (PEMs) 
were further purified using the plastic adherence method described in detail in the 
previous chapter. The purity of attached cells was evaluated by use of the Giemsa 
staining method. Based on morphological features, over 90% of the plastic-attached cells 
were macrophages. Purified PEMs were used for immunizing mice as described below. 
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Monoclonal antibody production 
    Monoclonal antibodies against chicken peritoneal macrophages were raised according 
to previously published protocols used routinely in our lab (Chen et al., 2010b). Three 
female BALB/c mice received i.p. injections of 5 x 10
6
 S-PEMs five times with a three-
week interval. The mouse with the best immune response against S-PEMs as judged by 
immunocytochemistry (ICC) was activated by i.p. injection of 5 x 10
6
 PEMs at three and 
five days prior to splenocyte harvest. The selected donor mouse was sacrificed, a single-
cell splenocyte suspension prepared, and splenocytes fused with Sp2/0 myeloma cells 
(ATCC, Manassas, VA) at a ratio of 2:1 by electrofusion using an Electro Cell 
Manipulator® ECM 2001 (BTX, Holliston, MA). Hybridomas were plated in 96-well 
cell culture microplates (Nunc) with addition of cytokines (Berghman et al., 1992) to 
sustain single parent cell growth and drug selection medium (containing standard 
concentrations of hypoxanthine, aminopterine, and thymidine (HAT) was applied for 
seven days. Primary screening was performed by immunocytochemistry (ICC) on day 14 
post-fusion using slides coated with S-PEMs or LPS-activated S-PEMs. Briefly, S-PEMs 
were washed three times with ice-cold PBS, pH 7.4, followed by fixation on poly-L-
lysine coated slides using 4% (w/v) paraformaldehyde in PBS, pH 7.4, for 10 minutes. 
Non-specific binding sites on the cells were blocked for one hour with 10% (v/v) goat 
serum in TBST [25 mM Tris-HCl, pH 7.6, 0.15 M NaCl, 0.1% Triton X-100 (v/v)] at 
room temperature. Each slide was then incubated with 3mL hybridoma supernatant at 
room temperature for four hours, followed by incubation with FITC-conjugated goat 
anti-mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) diluted 1000-
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fold in TBST at room temperature for one hour. Finally, slides were mounted with 
fluorescence anti-fading reagent containing DAPI (VECTASHIELD). Specific staining 
on cells was visualized using a Zeiss Axioplan Microscope (Zeiss, Hamburg, Germany) 
and analyzed using Axio imager software (Zeiss). Fifty-two immunopositive clones were 
acquired.  From the initial 52 observed primary positive clones, the three most promising 
clones (based on ICC characteristics and hybridoma vigor) were selected for further 
study in the epitope identification assays described below.     
 
Flow cytometry  
    In order to identify the antigens corresponding with Mabs 3A8 and 4A5, it would be 
preferable to perform immunoprecipitation and mass spectrometric analyses. Such 
studies require a relatively large amount of protein. Therefore, access to alternative 
sources of the antigen, other than primary macrophages, would be preferable. Therefore, 
flow cytometric staining was carried out to assess and quantify potential cross-reactivity 
of our new Mabs with established chicken macrophage cell lines (HD11 and MQ-
NCSU) (Beug et al., 1979; Qureshi et al., 1990).  
    Briefly, Fc receptors on HD11 and MQ-NCSU macrophages were blocked with 
purified mouse immunoglobulin at 200μg/ml for 30 minutes at 4oC prior to staining, and 
the Lightening-link labeling kit (Innova Biosciences) was used to directly label Mabs 
3A8 and 4A5 (or mouse IgG2b, the negative control) with R-Phycoerythrin according to 
the manufacturer’s instructions. HD11 and MQ-NCSU cells (5 x 105) were incubated 
with various dilutions of R-Phycoerythrin-labeled 3A8 or 4A5 for 30 minutes at 4
o
C, 
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followed by fixation with 2% paraformaldehyde in PBS, pH=7.4. Flow cytometric 
analysis was performed using the FACSCalibur system (BD), and data were analyzed 
using FlowJo version 8.8.4 software (Tree Star, Inc., Ashland, OR). Data were expressed 
as percentage of total cells stained specifically by the new Mabs. The levels of staining 
were shown as median fluorescence intensity (MFI) ratios. Student’s t-test was be used 
to determine significant differences between treatments. The results were expressed as 
mean ± SD. All data were analyzed using JMP® version 9 software (SAS Institute Inc., 
Cary,  NC). 
 
Epitope mapping by screening with a commercial peptide phage display library  
    A peptide phage display library (New England Biolabs, Ipswich, MA) was used for 
epitope mapping in an attempt to directly identify the epitopes recognized by 
immunopositive hybridoma clones. This filamentous phage library displays linear 7-
residue peptides with random sequences on the surface of the M13 phage. The random 
heptapeptides are fused to the N-terminal end of the phage’s minor coat protein (pIII) via 
a 4-amino acid spacer (GGGS) (New England Biolabs, Ipswich, MA). The library was 
used according to manufacturer’s instructions for screening Mabs 3A8, 3F6, and 4A5. 
The 7-mer phage display library provides the complexity on the order of 10
9
 independent 
clones, which makes it sufficient to encode 1.28 x 10
9
 possible 7-mer linear amino acid 
sequences for epitope mapping.  
    Briefly, purified Mabs 3A8, 3F6, or 4A5 (10µg/ml) were first coated onto 96-wells 
polystyrene plates in an alkaline bicarbonate buffer (0.1 M NaHCO3, pH=8.6) overnight 
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at 4˚C. The Mab-coated wells were then blocked with blocking buffer (0.1 M NaHCO3, 
pH=8.6) containing 5 mg/ml BSA and 0.02% (w/v) NaN3) for 1 hour at 4˚C. The ELISA 
plate was washed 6 times with TBST [TBS containing 0.1% (v/v) Tween-20] while 
avoiding that the wells would dry out. 
    The phage library was prepared by diluting it 100-fold with TBST (to a working 
solution of ~2 x 10
9
 clones/100 µl), applied to each well, and then incubated for one hour 
at room temperature. The supernatant was discarded and the wells were washed 10 times 
with TBST. Bound phages were eluted with 100 µl elution buffer (0.1 M glycine-HCl, 
pH=2.2) and immediately neutralized by addition of 150 µl neutralizing buffer (1 M 
Tris-HCl, pH=9.1). An early log phase (OD600 = 0.01-0.05) suspension of Escherichia 
coli (ER2783) in LB media containing tetracycline was prepared and the eluted phages 
were added to 20 ml ER2783 culture and incubated with vigorous shaking for 4.5 hours 
at 37˚C. The amplified phages obtained from this first panning round were then used as 
input phages for the next round of biopanning. The same procedures were repeated 
during two more rounds of screening while increasing the stringency of the washing 
conditions by increasing Triton X-100 concentration from 0.1%to 0.5% TBST. Phage 
clones were harvested after the third round of biopanning and individual clones were 
selected for the extraction of single-stranded phage DNA with iodide buffer (10 mM 
Tris-HCl, pH=8.0, containing 4 M NaI and 1 mM EDTA). The inserted portions of the 
phage DNA were sequenced with the -96 gIII sequencing primer 5’-
CCCTCATAGTTAGCGTAACG-3’ provided by the manufacturer and the nucleotide 
sequences were used to deduce the amino acid sequence of the encoded 7-mer peptides. 
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Alignment of the resulting sequences was carried out by use of the BLASTp database on 
NCBI, ensemble BLAST/BLAT, and UCSC BLAT search genome. The parameters of 
alignment search were adjusted for short peptide. The window size and the expected 
value cutoff were adjusted to 2 and 200, respectively. Moreover, the BLOSUM62 
scoring matrix was replaced by a more stringent PAM30, as an adaptation to work with 
short peptides. 
    The identified epitopes were located in the primary protein sequences and relevant 
domains were further analyzed using the Kolaskar and Tongaonkar antigenicity scale 
and Parker hydrophilicity prediction (Kolaskar and Tongaonkar, 1990; Parker et al., 
1986). 
 
Epitope specificity analysis by ELISA 
    In order to determine the specificity of the 7-mer peptide (GTHVQAT) acquired after 
phage display library biopanning, an ELISA binding assay with the synthetic 7-mer 
biotinylated peptide was carried out. Biotinylated peptide (GTHVQAT) was obtained 
from Genscript (Piscataway, NJ). Peptide was incubated with goat anti-biotin antibody 
(Thermo Fisher Scientific Inc.) on a rotator at 37˚C for one hour. A 96-well plate was 
coated with peptide-goat-antibody complex (10 µg/ml) at 4 ˚C overnight. After washing, 
100 µl of 3F6 Mab (10 µg/ml) was added and incubated for 4 hours at room temperature 
using a different Mab, 3A8, as the negative control. The 7-mer peptide-3F6 complex was 
then incubated with HRP-conjugated goat anti-mouse secondary antibody (Jackson 
ImmunoResearch) diluted 1:3000 with 3% (w/v) BSA in PBST for 30 min at room 
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temperature and washed prior to enzymatic color development. The color reaction was 
then developed using OptEIA™ TMB substrate (BD) according to manufacturer’s 
instructions. The reaction was terminated by addition of 1N sulfuric acid after incubation 
at room temperature for 1 min. Absorbances at 450 nm were measured in a Wallac plate 
reader (PerkinElmer Inc., Waltham, MA). 
 
Results 
Primary screening of new Mabs against S-PEMs by ICC 
    A primary screening of Mabs prepared by hybridoma technology was carried out by 
ICC against S-PEMs and LPS-activated S-PEMs. As shown in Fig. 12, three (3A8, 3F6, 
and 4A5) out of 52 clones reacted positively with S-PEM and LPS-activated S-PEMs. 
The staining patterns strongly suggested that the antigens recognized by the three new 
Mabs were located on the cell membrane. No positive staining was observed in the 
negative control (results not shown). 
 
Flow cytometric analysis of chicken macrophage cell lines, HD11 and MQ-NCSU, with 
Mabs 3A8 and 4A5  
    As shown in Figs. 13 and 14, Mabs designated 3A8 and 4A5 cross-reacted with 10 to 
20% of resting HD-11 and MQ-NCSU cells. Unfortunately, stimulation of the cells with 
LPS did not increase the percentage of cells reacting with either Mab; actually, the 
opposite happened. After incubation with LPS, the population of HD11 cells stained 
with Mab 3A8 significantly decreased from 18.30% to 5.68% (P<0.01), with mean  
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Figure 12. Primary screening of hybridomas raised against S-PEMs by immuno-
cytochemical staining of the chicken PEMs. Primary screening of hybridomas raised 
against S-PEMs by immuno-cytochemical staining of the primary cells used for 
immunization [(a) 4A5, (b) 3A8, and (c) 3F6] and of LPS-activated S-PEMs [(d) 4A5, 
(e) 3A8, and (f) 3F6]. Three out of 52 clones reacted positively with S-PEMs. Cells were 
fixed on poly-L-lysine coated slides using 4% paraformaldehyde in PBS, pH 7.4. FITC-
conjugated goat anti-mouse IgG was used for detection. Specific staining on cells was 
visualized using a Zeiss Axioplan Microscope (Zeiss, Hamburg, Germany) and analyzed 
using Axio imager software (Zeiss). 
 
 
(a) 4A5 (d) 4A5 
(c) 3F6 
(b) 3A8 
(f) 3F6 
(e) 3A8 
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Figure 13. Flow cytometric analysis of HD11 cells using Mabs 3A8 
and 4A5. The black bars represent resting HD11 cells and the gray bars 
represent LPS-activated cells (A) Percentage of HD11 macrophages 
stained with 3A8 and 4A5. (B) Mean fluorescence intensity (MFI) 
ratios under resting and stimulated conditions. HD11 macrophages 
were stained with 5 μg/mL R-Phycoerythrin-labeled 3A8 or 4A5. 
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fluorescence intensity (MFI) remaining unchanged. Similarly, Mab 4A5 staining on 
HD11 cells also declined from 12.39% to 5.32% after stimulation with LPS with 
unchanged MFI (Fig. 13). 
    The reaction patterns of 3A8 and 4A5 with MQ-NCSU cells were somewhat different; 
19.70% and 16.15% of resting MQ-NCSU cells were positively stained with Mabs 3A8 
and 4A5, respectively (Fig. 14). After treatment with LPS in vitro for 8 hours, the 
fraction of MQ-NCSU stained with both Mabs slightly decreased; however, the 
expression levels of antigens (as judged by the MFI values) recognized by Mabs 3A8 
and 4A5 on MQ-NCSU cells slightly increased (Fig. 14; P<0.05). 
    One of three Mabs (3F6) recognized a 7-mer peptide displayed by the peptide library 
after three rounds of biopanning. After sequencing, we found that eleven out of 20 
clones displayed a consensus 7-mer motif, Gly-Thr-His-Val-Gln-Ala-Thr (GTHVQAT) 
(Table 11). The specific interaction of this heptapeptide with Mab 3F6 was further 
validated by ELISA (Fig. 15). Despite adjusting the parameters of the searching 
algorithms to improve searching for a 7-mer overlap, no hits were found without 
mismatches or gaps in the publicly available chicken databases. Nevertheless, several 
proteins with only a one or two amino acid mismatches or gaps were identified. 
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Figure 14. Flow cytometric analysis of MQ-NCSU cells using mAbs 
3A8 and 4A5. The black bars represent resting cells and the gray bars 
represent LPS-activated cells (A) Percentage of MQ-NCSU 
macrophages stained with 3A8 and 4A5. (B) Mean fluorescence 
intensity (MFI) ratios under resting and stimulated conditions. MQ-
NCSU macrophages were stained with 5 μg/mL R-Phycoerythrin-
labeled 3A8 or 4A5. 
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*Consensus amino acid residues are highlighted in yellow. 
Table 11. Phage display library screening with Mab 3F6. After three rounds of 
biopanning with Mab 3F6, 20 phage clones were isolated and sequenced. The phage 
sequences were aligned using databases available on NCBI, Ensemble, and UCSC.  
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Figure 15. Analysis of peptide binding specificity by ELISA. The 96-
well plate was coated with biotinylated 7-mer peptide-goat anti-biotin 
antibody (10 µg/ml; GTHVQAT) at 4˚C overnight. After washing, 100 
µl of 3F6 Mab (10 µg/ml) was added and incubated for 4 hours at room 
temperature. The 7-mer peptide-3F6 complex was then incubated with 
goat anti-mouse polyclonal antibody conjugated with HRP (Jackson 
ImmunoResearch) diluted (1:3000) with 3% BSA in PBST for 30 min 
at room temperature. MAb 3A8 (an irrelevant Mab at the same 
concentration) was used as negative control. 
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Epitope mapping with phage display library technology 
    The search results of the bioinformatics algorithms were further narrowed down based 
on the following considerations. First, the staining patterns shown in Fig.12 indicate that 
the antigen recognized by Mab 3F6 is distributed on the cell surface of S-PEMs. Second, 
the typical length of a linear B-cell epitope is considered to be in the range of 4 to 20 
amino acids (Singh et al., 2013). Based on these premises, the candidate antigens were 
narrowed down by filtering with the following criteria: 1) classification as a cell surface 
receptor expressed on APCs and located in an extracellular domain, 2) use of an E-value 
smaller than 50 as significance threshold, and 3) acceptance of a matched motif at least 
four amino acid in length. The candidate antigen structure was further analyzed by 
SMART software (figure not shown; http://smart.embl-heidelberg.de/).  
    After further adjustment of the E-value to 200, the alignment algorithms revealed two 
candidate antigens as possible 3F6-binding antigens (Table 12 and 13): CD110 
(
379
HVQAT
383
) and protocadherin Fat1 (
3146
TrVQAT
3151
).  The antigenicity and 
hydrophilicity of the domains matching with the recognized antigens were analyzed by 
application of the Kolaskar and Tongaonkar antigenicity scale and the Parker 
hydrophilicity prediction. (http://tools.immuneepitope.org/tools/bcell/iedb_input) 
(Kolaskar and Tongaonkar, 1990; Parker et al., 1986). Both algorithms indicated that 
epitopes 
379
HVQAT
383
and 
3146
TrVQAT
3151
 were located within antigenic and 
hydrophilic regions (Table 13, Fig. 16, and Fig. 17).   
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Table 12. Sequences producing significant alignments with GTHVQAT 
(candidate antigens).  Eleven out of 20 sequenced phage clones revealed 
consensus sequences. 
Table 13. Motifs and domains recognized by Mab 3F6 in candidate antigens.  
 
*Bold letters denote an exact match to the residues of candidate antigens. 
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Discussion  
    A straightforward method to identify the specificity of a new Mab that does not 
require the availability of the original immunogen is to define the corresponding epitope 
by peptide phage display. A commercially obtained (New England Biolabs, Ipswich, 
MA) 7-mer random peptide phage display library displaying 1.28 x 10
9
 unique 
heptapeptides was used for this purpose. However, the limitation of this approach is that 
such a library only simulates linear peptides, whereas 90% of B-cell epitopes are -at least 
partially- conformational (Freund et al., 2009). As a consequence, not all epitopes can be 
identified using this phage display library approach. After three rounds of biopanning, 
Mab 3F6 was shown to interact with an enriched clone of the phage library displaying 
the heptapeptide GTHVQAT.  
    Two candidate antigen molecules, CD110 (
379
HVQAT
383
) and protocadherin Fat1 
(
3146
TrVQAT
3151
), were identified in silico. B-cell epitopes must be solvent-accessible, 
so they tend to be on the surface of the antigen, indicating a higher hydrophilicity is 
necessary. Algorithms designed to identify highly antigenic and hydrophilic properties 
based on protein primary structure indicated that the target motif GTHVQAT was indeed 
located in extracellular domains in both antigens. Protocadherin Fat 1 is mostly 
expressed on smooth muscle cells and plays an essential role in cellular polarization, cell 
migration, and modulation of cell-cell contact (Moeller et al., 2004; Tanoue and 
Takeichi, 2005). However, to our knowledge, the expression and function of Fat1 on 
chicken APCs have not been reported. On the other hand, CD110, also called 
myeloproliferative leukemia virus oncogene (c-Mpl), is a receptor for thrombopoietin 
  
99 
 
(TPO). Initially, it was thought to only be expressed on megakaryocytes and platelets. 
However, recent studies indicate that CD110 is also expressed on erythroid, granulocyte-
macrophage progenitor cells (Segerer et al., 2013). Kawamoto et al. (2013) 
demonstrated that CD110 is expressed on blood-derived monocytes in the presence of 
TPO (Kawamoto et al., 2013). Finally, expression of CXCR4 mRNA (a homing receptor 
ligand in peripheral lymphoid tissue) has been shown to be up-regulated in the presence 
of TPO-CD110 ligation in mammals. So far, no literature evidence was published 
regarding CD110 expression and function in chicken APCs. Despite the high E-value 
and a partial mismatch in the result, the current study demonstrates that phage display of 
a random short peptide library is a powerful technique for epitope mapping.  
    Since Mabs 3A8 and 4A5 were unable interact with the phage display library, the 
combination of immunoprecipitation, mass spectrometry, and computer-based epitope 
prediction may be needed in future studies (Katz et al., 2007; Shevchenko et al., 2006). 
This will require a sufficiently large amount of S-PEMs as the source of protein. The 
availability of a consistent and relatively abundant source of antigen for 
immunoprecipitation is thus a concern, because the generation of primary S-PEMS is 
relatively complicated and cumbersome process.   
    Therefore, we have evaluated the possibility of using immortalized chicken 
macrophage cell lines as a surrogate antigen source. Our analysis has shown that such an 
approach may be prone to a number of problems.  
    The flow cytometric results indicated that both Mabs 3A8 and 4A5 stained a 
surprisingly small fraction of both HD11 and MQ-NCSU cells, and this situation could 
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not be ameliorated by prior stimulation with LPS. Macrophages frequently change their 
phenotypes based on the microenviroment from which they are exposed (Davis et al., 
2013). In some cases, the in vivo functional phenotype of primary cells requires the 
synergy of multiple signals together, and this event cannot be replicated in an 
immortalized cell model in vitro (Chiang et al., 2008; Pan et al., 2009). The components 
in the peritoneal milieu are complicated, and next to C3b-bound particles, a number of 
synergizing agonists or  antagonists may be involved in the in vivo activation of S-PEMs 
(Stout and Suttles, 2004). Thus, macrophage cell lines culture in vitro may not be able to 
mimic the microenviroment in vivo.   
    We can conclude that while MQ-NCSU may be a better substitute for S-PEMs than 
HD11 cells as the source of membrane proteins. However, fewer than 20% of the cells 
appeared stained by 3A8 and 4A5, which indicates that an in vitro macrophage cell line 
may not be a good choice as a substitute for S-PEMs.   
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CHAPTER VI  
CONCLUSION 
    In our first study, we have demonstrated that a single parenteral (s.c.) or mucosal 
immunization with an anti-cCD40 Mab-guided antigen complex can induce not only a 
fast and long-lived systemic IgG immune response, but also a rapid local mucosal sIgA 
response. Specific IgG detected in circulation at an early stage post immunization 
indicates that the CD40 engagement mimics the biological role of CD4+ T cells by 
targeting APCs, including B-cells, and further enhancing CD40 downstream signaling 
and subsequent immunoglobulin class-switching from IgM to IgG. Interestingly, we also 
observed that an anti-CD40 Mab 2C5-peptide complex was capable of inducing a 
specific sIgA immune response in tracheal mucosa extracts after a single s.c. injection. 
This result seems to indicate that a gateway similar as the one that has been described in 
the common mucosal immune system (CMIS) also exists between systemic (peripheral) 
and mucosal immunity. We hypothesize that this involves expression of mucosal homing 
receptor (CCR10) by CD40-activated memory B-cells, which provides capability to 
migrate to mucosal effector sites.   
    The concept of an anti-cCD40 Mab-guided immunogen complex has great potential as 
a targeting system for a broad variety of antigenic cargo which can be widely used for 
immunization of chickens through mucosal and/or parenteral administration when the 
systemic and mucosal immunity are both highly desirable.    
    In our second study, we functionally phenotyped the two most frequently used 
primary macrophage models in chicken: Sephadex-induced – and egg yolk-elicited 
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peritoneal exudate macrophages (S- and Y-PEMs), using functional phenotype assays 
and gene expression profiling. This study indicates that certain indicators are considered 
as “specific” M2 markers in mammals do not behave the same way in chicken. These 
include arginase activity, gene expression of the SOCS1/STAT3 axis, and 
SOCS1/SOCS3 ∆Ct ratio. Thus, these markers cannot be used in chicken. Discrepancies 
could be the consequence of phylogenic separation of chickens from mammals about 
300 million years ago, but could also be caused the fact that Y-PEMS have to be 
manipulated by a plastic adherence purification process prior to phenotypical 
characterization. Plastic adherence can be considered as a pro-inflammatory, M1-
polarizing factor. . Our results clearly suggest Sephadex elicitation skews the phenotype 
of avian macrophages to the M1 phenotype. Despite the conflicting gene expression 
profiles mentioned above, we do support the view that egg yolk elicitation shifts the 
avian macrophage phenotype towards the M2 pole, especially when taking into account 
their low level of iNOS mRNA expression.  
    In the final study, three new Mabs against S-PEMs were generated. We have identified 
two candidate antigen molecules, CD110 (a receptor for thrombopoietin) and 
protocadherin Fat 1, recognized by Mab 3F6 by using a random 7-mer peptide phage 
display library. In mice, the expression of CXCR4 mRNA (a homing receptor ligand for 
peripheral lymphoid tissue) was shown to be up-regulated in the presence of 
Thrombopoietin-CD110 ligation. These results suggest that S-PEMs have the potential to 
migrate to peripheral lymphoid tissue as APCs in chicken. Despite the inability to 
delineate conformational epitopes, random 7-mer peptide phage display is a powerful 
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tool for epitope mapping. We further tested the cross-reactivity of the remaining two 
Mabs with immortalized chicken macrophage cell lines (HD11 and MQ-NCSU) in order 
to assess their potential to serve as a surrogate source of macrophage antigens for the 
further testing. However, only a surprisingly low level of HD11 and MQ-NCSU 
macrophages were stained with both Mabs, indicating chicken macrophage cell lines 
have a limited potential to substitute S-PEMs.   
    The poultry industry needs a new generation of vaccines for the induction of both 
mucosal and system immunity in a single immunization. The antibody-guided CD40-
targeting concept described in this study may provide a new platform that can fit this 
need.  
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